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Abstract 
Human Papillomavirus (HPV) was the most common sexually transmitted disease in the 
United States in 2018 according to the Centers for Disease Control and Prevention 
(CDC). The CDC established the Healthy People 2020 initiative for HPV vaccination 
uptake of 80% to effectively eliminate HPV associated cancers. The project site, a rural 
multispecialty clinic in the Mid-Atlantic United States reported a 3% vaccination 
compliance rate, well under the national average and the benchmark of 80% 
recommended by the CDC. The practice-focused question for this project was to 
determine how education of primary providers will increase recommendation rates for 
vaccination of HPV. Pender’s health promotion model provided key elements to 
evaluating barriers to vaccination and developing strategies to overcome barriers to 
recommendation. The search engines and databases used for the educational framework 
on the vaccination recommendation improvement project included CINAHL, 
MEDLINE, ProQuest, and OVID Nursing Journal review. Search terms included HPV 
vaccination, adherence, vaccination surveys, education, primary provider, health 
promotion, advocacy, and immunization barriers. An urgency statement was developed 
as a 1-page significant information sheet on the facts about HPV, vaccination risks and 
benefits, and barriers to vaccination. The vaccination data report obtained from the DNP 
project multi-specialty site revealed that post urgency recommendation had improved 
from a 3% baseline recommendation rate to 100% for the in-office clinic visits. Vast 
positive social changes can be made to promote health as it relates to HPV infection and 
elimination of HPV associated cancers globally. 
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Section 1: Nature of the Project 
Introduction 
Human Papillomavirus (HPV) was the most common sexually transmitted disease 
in the United States in 2018 (Van Dyne et al., 2018). The Centers for Disease Control and 
Prevention (CDC) established the Healthy People 2020 initiative for HPV vaccination 
uptake of 80% to effectively eliminate HPV-associated cancers. Both men and women 
are being diagnosed with HPV-related cancers despite health care initiatives and provider 
awareness campaigns. With 14 million new cases per year in the United States alone, the 
American Cancer Society has made new a new goal for the year 2026 that would support 
that 80% of preteens 11-12 years old will receive the vaccine before their 13th birthday 
(Fedewa et al., 2018). In efforts to identify the barriers to meeting vaccination rates 
community leaders around the world have made poor HPV vaccination rates a global 
pandemic priority (Fedewa et al., 2018). Cervical and oral cancer diagnoses continue to 
reach numbers larger than 500,000 per year (Senkomago et al., 2017). There is 
significance in HPV vaccination as a public health problem because after more than a 
decade of HPV vaccination awareness, providers are still coming up short with 
recommendations to vaccinate (Niccolai, North, Footman, & Hausen, 2018). 
Recommendations to vaccinate have been identified as the most significant predictor of 
vaccination adherence among the preteen population, demonstrating how a provider-
focused project will create social change (Niccolai et al., 2018). The DNP project was to 
create a platform to assess the barriers to HPV vaccination recommendation in the 
provider population and then deliver evidence-based urgency statements on HPV 
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guidelines that in turn will increase knowledge and reduce or eliminate barriers to 
recommendation. Section 1 will present the problem statement, purpose, significance, 
nature of the project and summarize the project objectives as they relate to creating a 
platform to educate providers towards recommendation of HPV vaccination. 
Problem Statement 
HPV infection is recognized by the CDC to be the most common sexually 
transmitted disease in the United States, with more than 14 million new cases confirmed 
every year in the United States (Cole, Thomas, Straup, & Savage, 2017). Our local 
problem focus is on assessing barriers to recommendations for prescribing the HPV 
vaccination within the primary provider population. Conducting a vaccination adherence 
project in a multidisciplinary clinic increases the feasibility of vaccination, as these 
clinics have certified family practice, internists, and pediatrician providers. The Mid-
Atlantic region falls along a religious beltway in the United States that sets precedent for 
religious beliefs to impact vaccination adherence. Although categories for exemption 
include medical exemptions, in this region these exemptions only account for 0.4% of the 
total 4.1% of the total nonimmunized students, with the religiously exempt students 
making up the largest group of unvaccinated children in the county, at just under 2% 
(Capps, 2019). The project clinic identified itself as religiously based, and the providers 
reported affiliation to religious barriers to conversations that were in any way connected 
to sexual activity. Also, anti-vaccination protestors had strong emotional responses to 
risks related to vaccines, and providers had knowledge gaps about the risk-benefit profile 
for HPV vaccination specifically. Any decrease in vaccination adherence has been proven 
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to have a direct and inverse effect on risk for transmission of the disease (Capps, 2019). 
Perhaps the most significant measure for poor vaccination in the region is lack of access 
to care. Lack of access in this region can be explained by the rural nature of surrounding 
counties. The county health department reports that there are higher numbers of parents 
reporting lack of access to care related to time and travel to care centers as compared to 
anti-vaccination philosophies (Capps, 2019). 
Evidence of a global pandemic has resulted in the CDC recommending HPV 
vaccination penetrance of 80% in the population as part of the Healthy People 2020 
initiative, but efforts have proved futile as actual vaccination rates remain closer to 57% 
in the United States (Sussman et al., 2015). While researchers evaluate why vaccination 
adherence remains low, there is growing concern about HPV-related cancers. There are 
33,000 cancers caused by HPV every year in the US, with an associated cost to treat 
noted to be greater than $7 billion (Fisher-Borne, Preiss, Black, Roberts, & Saslow, 
2018). The World Health Organization (WHO) data indicate that despite vaccination 
efforts and screening these numbers are now globally reaching 570,000 HPV-related 
cancers in women and 60,000 cancers in men per year (St. Laurent, Luckett, & Feldman, 
2018). If vaccination rates reach the 80% goal, vaccine models suggest that the HPV 
infection would be completely eradicated, and cancer deaths could be reduced to 20% 
globally (Brisson et al., 2016). 
Purpose  
Although many socioeconomic and behavioral factors have impacted the 
vaccination rates for HPV, it is the consensus that involving clinicians, parents, and the 
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adolescent patient in the discussion around vaccination will improve adherence (Cole et 
al., 2017). Lollier, Rodriguez, Saad-Harfouche, Widman, and Mahoney (2018) described 
how primary provider knowledge and support is a common theme to vaccination 
adherence and disease prevention. The project site has reported a 3% vaccination 
compliance rate, which is well under the national average and the benchmark of 80% 
recommended by the CDC. Although there are ample providers in the project site 
provider group treating preadolescent patients, poor vaccination adherence is a 
multifactorial problem. Vast social impacts can be made to positively promote health as it 
relates to sexually transmitted HPV and elimination of associated cervical and oral 
cancers locally and around the world. The practice-focused question for the identified 
problem of poor HPV vaccination rates was, Will educating primary providers in a 
multidisciplinary clinic on the current state of HPV result in increasing HPV vaccination 
knowledge and recommendations for vaccination of eligible preteens to 80%?  
The practice-focused question was to determine how education of primary 
providers will increase knowledge and recommendation rates for preteen vaccination of 
HPV. There is significance in HPV vaccination as a public health problem because, after 
more than a decade of HPV vaccination awareness, providers are still not meeting the 
recommendations to vaccinate (Niccolai et al., 2018). Recommendation to vaccinate has 
been identified as the most significant predictor of vaccination adherence among this 
population (Niccolai et al., 2018).  
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Nature of Project 
The search engines and databases used for an educational framework on 
vaccination recommendation improvement project included CINAHL, MEDLINE, 
ProQuest, and OVID Nursing Journal review. I also consulted trusted websites including 
the CDC, National Vaccination Advisory Committee (NVAC), the WHO, and Advisory 
Committee Immunization Practices (ACIP). Search terms included HPV vaccination, 
adherence, vaccination surveys, education, primary provider, advanced practice nurse, 
nursing model and theories, health promotion, advocacy, lack of access, and 
immunization barriers. Clinics with specialty providers have an inter collaborative 
approach and are increasingly likely to appoint vaccine champions, use standardized 
policies, and schedule appropriate time to visits scheduled for vaccination (Lollier et al., 
2018).  
The approach for the DNP project was focused on applying advanced practice 
nursing principles to make meaningful impacts in this area by disseminating and 
translating research. The use of Pender’s health promotion model (HPM) provided key 
elements to evaluating perceived and actual barriers to vaccination and develop strategies 
to overcome barriers to recommendation (HPM, n.d.). The medical director provided 
oversight of the process in which the nurse vaccination champion provided vaccination 
data on how many vaccination recommendations occurred from participating providers in 
the month prior to my initial visit for pre-education preparation. The champion was a 
designated nurse trained in vaccination procedure who had access to an electronic 
database from which she obtained statistics on provider recommendations, numbers of 
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patient visits, and percentages of adherence to HPV vaccine recommendations. The nurse 
champion created and then printed the deidentified worksheet for me when I arrived for 
the pre-education phase of the project. Prior to my pre-education visit I made a project 
initiation visit and delivered the providers a pre-education survey titled “WD4019: You 
Are the Key to HPV Cancer Prevention-2018” to identify barriers to vaccination 
recommendation. The paper survey was adapted from an existing approved survey from 
the CDC, took less than 5 minutes to complete, was delivered to the nurse’s station by the 
nurse champion and collected with no identifiers (Vaccines CDC, 2019). Providers 
completed the de-identified surveys and returned them to the nurse champion who placed 
the surveys in an envelope titled “Pre-Education Survey” and kept the completed surveys 
in her locked, private office until my return for the pre-education visit. The vaccination 
champion obtained the vaccination recommendation report and provided it to me during 
my visit in a separate envelope marked “Vaccination Recommendation Report”. All the 
data were kept deidentified and secured in the private office of the nurse champion.  
I collected and evaluated the data report, the results from the pre-education 
survey, current literature from the CDC and current peer reviewed literature in order to 
develop an urgency statement. The urgency statement was a one-page statistically 
significant information sheet on the facts about HPV, vaccination risks and benefits, and 
ways to overcome barriers to vaccination. The urgency statement on HPV and 
overcoming barriers was aligned with support from the literature with ways to reduce 
barriers as they have been identified from pre-assessment surveys. The pre-education 
phase of the project occurred over a 1-week period. 
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Visit number two occurred 1 week after the pre-education visit and marked the 
initiation of the education phase of the project. The medical director attended an 
educational in-service in the clinic breakroom along with providers on hand for patient 
care were given a copy of the urgency statement to use a guide over the next month in 
their clinical practice. I delivered the educational content from the urgency statement to 
the providers and the nurse champion in the centralized breakroom in the clinic. I 
presented the findings from the presurvey and the current data on the HPV virus, 
vaccines and barriers as they were identified on the survey in an open discussion format. I 
used a poster as an aid to present the information that aligned with the vaccine from the 
CDC as well during the discussion. The providers had an opportunity to ask questions 
during and after the in-service. The providers and clinic nurse were able to reach me via 
email if they had questions regarding vaccination recommendations or the material 
presented in the in-service for a month after the education phase. The education phase 
occurred over a 4-week period. 
Visit number three occurred 5 weeks after the delivery of the urgency statement 
and evidence-based guidelines. During the post education visit I returned to the clinic to 
give the post education survey titled the “WD4019: You Are The Key to HPV Cancer 
Prevention-2018” to the nurse champion who delivered it to the providers to complete in 
the centralized nurses station. Providers completed the deidentified surveys and returned 
them to the nurse champion who placed the surveys in an envelope titled “Post-Education 
Survey” and returned them to me during my visit. The vaccination champion obtained the 
vaccination recommendation report from the electronic record and provided the results to 
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me during my visit in a separate envelope marked “Vaccination Recommendation 
Report”. All the data were kept deidentified and secured in the private office of the nurse 
champion. The data were transferred to an electronic spreadsheet that was password 
protected and encrypted to examine the breakdown of which barriers were chosen. 
Finally, the post education evaluation occurred 1 week after data were received from the 
champion and entered on the spreadsheet. I analyzed the data from the presurvey and 
postsurvey and the data on vaccination recommendation rates before and after education 
to evaluate if the educational in-service closed the gap on the knowledge deficit and 
reduced barriers to vaccination recommendations within the provider group. The total 
project time was 6 weeks from preassessment to analysis of the results.  
The purpose of this project was to demonstrate that primary providers had a direct 
and positive influence on HPV vaccination recommendations and adherence. In-service 
and urgency statement delivery reduced barriers and closed the knowledge gap for 
providers responsible for HPV vaccination. Fisher-Borne et al. (2018) discussed how 
Federally Qualified Health Centers are eligible for grant monies for efforts to increase 
vaccination rates. Providers disseminate evidence-based practices by using collaboration 
strategies in strategic program development to ensure high levels of participation and 
demonstrate a positive return on investment to improve quality of care within the 
provider population in any wellness related program such as vaccination (Palumbo, 
Sikorski, & Liberty, 2013). 
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Significance  
The primary stakeholder was the primary provider who benefitted in the 
education model for vaccination recommendation by supporting the Healthy People 
initiatives and supporting healthy living by preventing disease in their patient 
populations. The preteen patient and parents were the secondary stakeholders who 
directly benefitted from an HPV provider education by experiencing better wellness and 
health outcomes. Many socioeconomic and behavioral factors have impacted the 
vaccination rates for HPV, but it is the consensus that involving clinicians, parents and 
the adolescent patient as stakeholders in the discussion around vaccination will improve 
adherence (Cole et al., 2017). Lollier et al. (2018) described how primary provider 
knowledge and support is a common theme to vaccination adherence and disease 
prevention. The four recommended vaccines for adolescents are tetanus, diphtheria, 
toxoid/acellular pertussis (Tdap), meningitis, influenza, and HPV with adherence rates 
between 80 and 90% for the first two (Lollier et al., 2018). The discrepancy between the 
three commonly administered vaccinations and HPV vaccination is believed to be due to 
health care provider barriers including limited knowledge, the stigma around sexual 
activity discussion and young age, parental perceptions and lack of awareness (Cole et 
al., 2017). Therefore, educating the providers on the facts of HPV vaccination, risks, 
benefits and indications has in turn equipped them to have the same impact when 
discussing the topic with patients and result in higher vaccination adherence. Because 
HPV infections usually do not cause symptoms and transmission of the disease occurs 
from sexual behaviors, the preteen and parent must rely on the provider to openly 
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communicate about priority risk reduction (Cole et al., 2017). Therefore, the primary 
provider is primarily responsible for addressing these barriers to recommending 
vaccination and holds the most influence on outcomes (Niccolai et al., 2018).  
Contribution of the DNP project can be accomplished by educating the providers 
in multispecialty care using health promotion frameworks. As a DNP, I can provide an 
urgent and informative delivery on the need for HPV vaccination and list facts related to 
possible side effects. I can also provide ways to remove or overcome barriers in order to 
open dialogue between patients, parents, and providers around risky sexual behavior and 
cancer prevention through nursing science and education models. Many attitudes and 
personal biases existed in the vaccination discussion, and educating using an evidence-
based framework has demonstrated ways to limit bias in approaching the topic of 
vaccination with eligible preteens and their parents.  
By effectively using an applied theoretical framework in nursing, such as the 
health promotion or health belief model, advanced practice nurses may in turn act as a 
liaison between disciplines and show application to clinical practice as education 
improves outcomes. The evidence justifies HPV vaccination as an imperative importance 
to the nursing profession. Assessing behavioral factors in healthy and non-healthy 
individuals is a key role for a professional nurse, as is the ability to help patients maintain 
health through educational measures or framework. When assessing how behavioral 
factors such as perceived risks and benefits to vaccination are relayed from provider to 
patient, Pender’s HPM will provide the framework on which to base recommendations 
for change. Education projects striving to increase vaccination recommendations may be 
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transferred to other large-scale communicable disease prevention platforms. However, 
advanced providers understand that HPV-related cancers continue at a staggering rate 
because vaccination adherence remains less than 80% as recommended by the CDC 
(Sussman et al., 2015). To significantly reduce infections and eliminate HPV-related 
cancers, providers worldwide must remain advocates for their vulnerable patient 
populations locally and globally through education, policy advocacy and by avoiding 
personal bias and barriers to recommendation. Education frameworks can be used across 
disciplines to make the kind of positive and measurable impacts to prevent disease in 
nursing, medicine, social sciences, and beyond. 
Vast positive social changes can be made to promote health as it relates to 
sexually transmitted HPV and elimination of associated cervical and oral cancers locally 
and globally. HPV infection is pandemic, and the intervention has the potential to make 
positive impacts on our local, national, and even global communities (Fedewa et al., 
2018). Because HPV is a sexually transmitted infection, the healthcare provider focus 
should be on education regarding cancer prevention to necessitate adherence. As an in-
service-related staff education project, measured outcomes to improve patient care and 
achieve standards of practice have become a part of the framework and program 
objectives for this clinic and included identifying the programs’ impact on social change. 
Summary 
The CDC established the Healthy People 2020 initiative for HPV vaccination 
uptake of 80% in effort to effectively eliminate HPV associated cancers. Both men and 
women are being diagnosed with HPV-related cancers despite health care initiatives and 
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provider awareness campaigns. The primary project goal is to increase HPV vaccination 
recommendation rates for children aged 11-13 years by improving the vaccination 
knowledge and recommendations to greater than 80% in the month post education. 
Vaccination administration rates at the project site were reported at 3% over the last 
quarter, believed to be due to many behavioral barriers. The practice-focused question 
was, will educating the primary providers increase knowledge and recommendation rates 
for preteen vaccination of HPV. The use of Pender’s HPM provided key elements of a 
framework to determine perceived and actual barriers to vaccination and develop 
strategies to overcome barriers to recommendations for HPV vaccination. The nature of 
the project was focused on health promotion activity through vaccination 
recommendation. Vaccination recommendation rates in the provider target population 
were evaluated using Pender’s HPM assumptions around actual and perceived barriers. 
Social impacts were made to positively promote health as it relates to sexually 
transmitted HPV and elimination of associated cervical and oral cancers locally and 
globally. Section 2 presents the background and context for the DNP project by 
describing appropriate models and theory relevant to nursing practice and explaining the 
role of the DNP student within the context of program implementation. 
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Section 2: Background and Context 
Introduction 
The purpose of the project was to provide urgency-based education to 
multispecialty providers in order to increase their knowledge on the current standard of 
care for recommendations for HPV vaccination and identify and reduce barriers to HPV 
vaccination in the preteen patient population. The problem question was, will educating 
primary providers on the urgency and barriers to HPV vaccination increase HPV 
vaccination recommendation rates for preteen patient populations. The following section 
will discuss how Pender’s HPM is an appropriate theory to demonstrate support for HPV 
vaccination recommendation and creating social change. Section 2 also identifies 
relevance to nursing practice application, gives local background and context, and 
elaborates on the role of the DNP student. 
Concepts, Models, and Theories  
The theory applied to the project is a middle range nursing theory that integrates 
nursing and behavioral science concepts called the Pender’s HPM (McEwen & Wills, 
2014). The HPM is an extension of the social cognitive theory, a grand theory evaluating 
behaviors within social science. The HPM holds assumptions that largely evaluate 
psychosocial behaviors of individuals and communities in order to engage them in 
learning new behaviors that are geared toward health promotion, not just illness 
avoidance (McEwen & Wills, 2014). Major concepts under the HPM include personal 
experiences and bias (McEwen & Wills, 2014). Behavioral considerations are the major 
underpinnings to the HPM. Behavior specific cognitions include perceived barriers and 
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benefits to action, perceived self-efficacy, activity related effects, interpersonal and 
situational influences (McEwen & Wills, 2014). Behavioral outcomes include the 
commitment to a plan of action that may be impacted by a person’s preference and own 
health promoting behaviors (McEwen & Wills, 2014). 
The HPM supported my vaccination recommendation program specifically by 
describing how vaccination recommendation enables the provider to encourage people 
towards disease prevention and engages individuals to take care of their community. 
Vaccines not only promote healthy behaviors, they also reduce rates for comorbid 
conditions that follow in population families, schools, workplaces and larger 
communities (Senkomago et al., 2017). Education on HPV also requires discussion on 
other health promotion activities, such as safe sex practices and screening with cervical 
exams (Senkomago et al., 2017). Individual provider behaviors and the culture within a 
provider practice may also place unseen barriers on the ability for providers to 
recommend the vaccine in eligible patients (Senkomago et al., 2017). By using the HPM, 
the DNP prepared nurse may then have the means to identify actual and perceived 
barriers of those providers responsible for recommending the vaccine. The practitioner 
will then gain insight into how to reduce or eliminate barriers identified in the survey to 
improve vaccination recommendation strategies. Nursing models in practice change 
allow a catalyst for advanced practice nurses to demonstrate a cross discipline application 
and close gaps in continuity of care (McEwen & Wills, 2014). While the providers in the 
target practice population will not be provided education on the model directly, they may 
have a general awareness of how barriers are perceived or otherwise can affect health 
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promotion. Discussing barrier identification and allowing for anonymous replies in 
surveys will reduce stigma, and possibly fear, as it relates to health promotion around 
sexual behaviors in the patient. The project is asking the provider to reflect on personal 
barriers to recommendation as well as the perceived barriers among the parent population 
for the preteen. The survey used measured the perceived barriers to vaccination from the 
provider viewpoint and does not reflect the opinions of the parents or the preteen 
adolescent directly.  
Relevance to Nursing Practice 
HPV vaccination holds relevance in nursing practice as evident by the continued 
incidence and prevalence of HPV infection despite social and political efforts. After more 
than a decade of vaccination awareness, clinicians are continuing to record low rates of 
vaccination adherence in practice (Niccolai et al., 2018). Recommendation to vaccinate 
has been identified as the most significant predictor of vaccination adherence among the 
pre-teen population (Niccolai et al., 2018).  
Conducting a vaccination adherence project in a multidisciplinary clinic increases 
the feasibility of vaccination, as primary clinics have certified family practice, internists, 
and pediatrician providers (Niccolai et al., 2018). Clinics with specialty providers have an 
inter collaborative approach and are increasingly likely to appoint vaccine champions, 
use standardized policies and schedule appropriate time to visits scheduled for 
vaccination (Lollier et al., 2018). Vaccination services are provided through a nurse 
vaccination champion and office encounters. Considering age-appropriate demographics 
for HPV, the clinic had a vaccination adherence rate of 3% per month in a quarter year, 
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which is well under the national average and the benchmark of 80% recommended by the 
CDC (HPV Vaccines, 2019). Although there are ample providers in multispecialty group 
treating preadolescent patients, poor vaccination adherence is a multifactorial problem. 
Anti-vaccination protestors have strong emotional responses to risks related to vaccines 
and providers may have knowledge gaps about the risk-benefit profile for HPV 
vaccination specifically.  
Perhaps the most significant measure for poor vaccination in the region is lack of 
access. Lack of access in this region can be explained by the rural nature of surrounding 
counties. The county health department reports that there are higher numbers of parents 
reporting lack of access to care related to time and travel to care centers compared to anti 
vaccination philosophies (Capps, 2019 para. 7). 
The proposed project worked to fill in the gap to practice by using evidence-based 
practice standards. The standards of care that increase knowledge on the current state of 
HPV infection on the urgency statements during in-servicing were created from materials 
obtained from the CDC. By increasing knowledge on the problem of HPV infection and 
current standards to care for the provider, the project helped providers in turn become 
increasingly able to address the barriers to vaccination for their patients. For example, 
lack of access of care was identified as a significant barrier to vaccination 
recommendation and adherence. Once the lack of access barrier was identified, the 
provider referred to the urgency statement explaining to the adolescent that if they 
adhered to the vaccine  before age 15, the recommendation protocol would be reduced to 
two injections from the standard three (Lollier, et al., 2018), thus, reducing trips to the 
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center for care and improving access. Advanced practice nurses are positioned to make 
meaningful impacts in vaccination compliance by disseminating and translating research 
on barriers to vaccine recommendation. The use of Pender’s HPM provided key elements 
to evaluating for perceived and actual barriers to vaccination and develop strategies to 
promote social change (McEwen & Wills, 2014). 
Local Background and Context 
Locally, the public commissioner of health and the CDC have reported that 
although national HPV vaccination rates among eligible adolescent patients are recorded 
at 40%, our state records an uptake of vaccination of only 30% (HPV Vaccines, 2018). 
The problem of HPV infection is reaching 45% of the U.S. population and is anticipated 
to grow if states do not react to find vaccination compliance strategies (HPV Vaccines, 
2018). Because recommendation to vaccinate is considered the number one predictor to 
vaccine acceptance, the vaccine initiatives have been a focus for providers and health 
systems across the country. In my state, and specifically at the multidisciplinary clinic 
where this project took place, vaccination recommendation rates have no monitoring 
policy. Tdap and meningitis vaccination adherence has grown to greater than 80% 
nationally as the initiatives for school-based admission programs have mandated 
vaccinations (American Academy of Pediatrics, 2019). While vaccination mandates are 
in place for Tdap, and meningitis, school systems across the United States have not 
mandated HPV vaccines related to the barriers around the sexually explicit nature of 
transmission (HPV Vaccines, 2018). In this region, barriers to recommendation include 
lack of access related to the rural location of the community and low socioeconomic 
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status that places adolescents at the threshold for poverty (Vaccines CDC, 2019). A 
multispecialty clinic in the region was identified to be a direct representation of the 
community’s at-risk population. The clinic employs 21 providers including pediatricians, 
primary internists, nurse practitioners and physician assistants. A needs assessment 
revealed that there was no tracking system for provider recommendations to vaccinate. 
The vaccine adherence rate measured for the clinic in the preliminary assessment was 
found to be 3%. The premise for the project was based on the CDC’s recommendation for 
HPV vaccination adherence to reach 80% (Vaccines CDC, 2019). 
The federal initiative for public health on HPV vaccination is called the Hub and 
Spoke Initiative ( AAP, 2019). In a collaboration with the CDC and the AAP, the 
Community Guide and the Hub and Spoke Initiative were formed. The priority of the 
Hub and Spoke Initiative is to focus on creating peer-guided accountability on strong 
provider recommendations for vaccination against HPV (AAP, 2019). The cultural, 
ethical, and legal obligations to promote wellness through vaccination becomes 
imperative in the framework of preventing the spread of HPV infection because 
infections are directly related to higher risk for cancer (AAP, 2019). With any illness that 
is spread through sexual transmission, a stigma and fear may be present, not just in the 
parental community, but the provider one as well (Fedewa et al., 2018). The DNP project 
is based on the Hub and Spoke initiative and legislation that focuses on prevention of 
disease by placing focus on provider recommendation strategies and peer to peer 
accountability (AAP, 2019).  
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The NVAC supports administration of the HPV vaccine at the same time 
meningococcal and Tdap vaccines are given, which is typically at 11 to 12 years of age 
(Cole et al., 2017). Because pediatrician providers have shown higher rates of vaccine 
administration awareness, the multispecialty provider clinic is an appropriate choice 
(Cole et al., 2017). Tdap and MCV4 vaccines are administered nationally at or above the 
80% benchmark, but do not include needed counseling or implementation strategies to 
overcome behavioral barriers associated with HPV (Lollier, et al., 2018). While 
pediatricians vaccinate at higher percentages compared to family practice providers, the 
rates for HPV vaccines are higher for girls as compared to boys, providing additional 
claim that screening in cervical cancer has increased the gap to vaccination between the 
sexes (Lollier, et al., 2018). 
Role of the DNP Student 
As a DNP student completing a practicum in a related field of Oral and 
Maxillofacial Surgery, I have a favorable referral base and a productive interdisciplinary 
professional relationship for an HPV vaccination project. Due to the compressed 
timeframe for data collection, I was unable to collect data for the full 6 to 12-month 
vaccination open period for series completion. However, it was feasible to complete a 
one-month post education data collection and monitor for increased vaccination 
recommendation over five weeks. The pre assessment identified perceived behavioral 
barriers to vaccination. The survey was adapted from current provider-based survey after 
the literature review and titled “WD4019: You Are The Key to HPV Cancer Prevention-
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2018.” I provided paper copies of the pre surveys and reference list to the nurse champion 
and she delivered them to the providers in the clinic.  
 I evaluated the data report, the results from the pre assessment survey and the 
current literature from the CDC and current peer reviewed literature in order to develop 
an urgency statement. The urgency statement was a one-page statistically significant 
information sheet on the facts about HPV, vaccination risks and benefits and identify 
ways to overcome barriers to vaccination. The urgency statement on HPV and 
overcoming barriers was aligned with support from the literature with ways to reduce 
barriers as they have been identified from pre assessment surveys. I presented the 
findings from the pre survey and the current data on the HPV virus, vaccines and barriers 
as they were identified on the survey in an open discussion format. I used a poster as an 
aid to present the information that aligns with the vaccine from CDC as well during the 
discussion. The providers had an opportunity to ask questions during and after the in-
service. The providers and clinic nurse were able to reach me via email if they had 
questions regarding vaccination recommendations or over material presented in the in-
service for a month post education. I returned to the clinic to give the post survey titled 
“WD4019: You Are The Key to HPV Cancer Prevention-2018” to the nurse champion at 
which time she delivered it to the providers to complete in the centralized nurses station. 
Providers completed the de identified surveys and gave them back to the nurse champion 
to place in an envelope titled “Post Education Survey” and returned them to me during 
my visit. Finally the post education evaluation occurred over one week, this is when I 
assimilated the data from the pre and post survey’s and the data on vaccination 
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recommendation rates pre and post education to evaluate for whether the educational in 
service closes the gap on the knowledge deficit and reduces barriers to vaccination within 
the provider group. 
My personal motivation for developing a project in the area of HPV vaccination 
was based on personal experience. As a nursing student in college I recognized a friend 
had a hard non movable “lump” along the cervical chain. The lump was misdiagnosed 
initially, but ultimately was found to be a malignant squamous cell filled lymph node. 
The etiology for the node was deemed likely to be related to a high-risk form of HPV. I 
feel a moral obligation to apply scientific knowledge and assessment of the infection, 
transmission, prevention strategies, and ways to overcome barriers where it will make the 
most positive impact and compel social change. As an advanced practice nurse, I am 
aware of the responsibility to prevent HPV infection in pre-teens and sexually active 
adults alike. HPV may also lie dormant and cause cancers to develop years or even 
decades after exposure (HPV Vaccines, 2018). As I grow to understand barriers to 
vaccination inside each target population, I have learned that the healthcare provider 
recommendation makes the most impact toward adherence (Lollier, Rodriquez, Saad-
Harfouche, Widman, & Mahoney, 2018). 
Oropharyngeal, cervical, anal, penile, and vaginal cancers are all continuing to 
occur in the United States despite awareness of the disease (Vaccines CDC, 2019). 
Cervical cancers have trended downward over the last fifteen years but may be related to 
increased screening along with vaccination in girls (Lollier, Rodriquez, Saad-Harfouche, 
Widman, & Mahoney, 2018). There are currently no screening recommendations that 
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have been shown meaningful for other types of cancers in women or men (Lollier, et al., 
2018). Barriers to vaccination are linked to demographics and socioeconomics (Cole et 
al., 2017). Communities should be educated on cancer prevention as a priority with HPV 
vaccination. The healthcare provider should stay up to date on current trends and speak 
knowledgably on cancer prevention. No person should suffer the consequences of a 
preventable cancer or related treatment, including surgical complications, swallowing 
difficulty, depression, pain, infertility, or any of the countless other potential life 
changing effects from chemo and radiation therapies (Coley, Hoefer, & Rausch-Phung, 
2018).  
Personal bias may exist related to the underlying passion I have for vaccination as 
a healthcare provider. I will address the bias by evaluating individual provider barriers 
without giving a personal context of accounts. It is my goal to identify provider barriers 
and use scientific knowledge from the literature to define ways to educate providers on 
ways to overcome their perceived or actual barriers without relation to anything outside 
of the research. By using the CDC education statements and modules on HPV vaccines I 
can avoid personal bias or interpretation. 
Role of the Project Team 
The project team consists of a medical director, nurse champion and the DNP 
student. The medical director had complete oversight of the process of data collection for 
the practice site and worked with the DNP student to liaison between the nurse champion 
and providers. The nurse champion works as a representative of the medical director and 
providers at the practice site. The nurse champion collected and stored all deidentified 
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data regarding HPV vaccination rates and delivered those to the DNP student prior to and 
post the education in-service visit. The nurse champion directed the DNP student to the 
nurse commons on the day of the urgency statement delivery and in-service.  
Summary 
By using theory and nursing health promotion models to build a provider 
education program I am positioned to make large social impacts in the area of HPV 
vaccination recommendation. Actual and perceived barriers to treatment have been 
shown to exist in the provider and patient groups within the context of vaccination 
outside of HPV. The same measures that are used in the CDC frameworks can be easily 
applied to the DNP project on vaccination. Because inter collaboration is an imperative 
part of research translation for practice, the DNP prepared nurse’s role in any vaccination 
project is to ensure that all identified gaps in care delivery are recognized and that 
barriers are reduced or eliminated. Empirical knowledge in nursing has proven to be a 
motivating factor for many advanced practitioners looking to make change. By recalling 
life events and applying evidenced based practices to experience allows for a deeper 
impact to be made. Personal bias in project programs can be eliminated if the DNP uses 
research to close gaps and keep dialogue open between healthcare disciplines. 
Section 3 discusses the collection method and study design as it relates to the 
problem focused research question. The research question of the DNP project asks how 
improving knowledge on HPV may improve provider recognition of barriers and 
recommendation for vaccination in the pre-teen adolescent. The section also provides an 
analysis and synthesis of the evidence as it relates to the project question. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
Evidence of a global pandemic has resulted in the CDC recommending HPV 
vaccination penetrance of 80% in the population as part of the Healthy People 2020 
Initiative, but efforts have proved futile as actual vaccination rates remain closer to 57% 
in the United States (Sussman et al., 2015). While researchers evaluate why vaccination 
adherence remains low, there is growing concern about HPV-related cancers. There is 
significance in HPV vaccination as a public health problem because, after more than a 
decade of HPV vaccination awareness, providers are still not meeting the 
recommendations to vaccinate (Niccolai et al., 2018). Because recommendation to 
vaccinate is considered the number one predictor to vaccine acceptance, the vaccine 
initiatives have been a focus for providers and health systems across the country.  
In my state, and specifically at the multidisciplinary clinic where this project took 
place, vaccination recommendation rates have no monitoring policy. The context of HPV 
vaccine recommendation is supported by evaluation of the barriers. Barriers including 
cultural, ethical, and legal obligations to promote wellness through vaccination become 
imperative in the framework of preventing the spread of HPV infection, because 
infections are directly related to higher risk for cancer (AAP, 2019). Many public health 
initiatives have been formed that support education frameworks and peer-guided 
oversight that may prove effective in strategy development for HPV vaccination such as 
the Hub and Spoke Initiative. Section 3 will present the practice-focused question, the 
sources of evidence, analysis and synthesis, and summary of the DNP project. 
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Practice-Focused Question  
Because HPV is a sexually transmitted infection, the healthcare provider focus 
should be on education regarding cancer prevention to necessitate adherence. Low 
vaccination administration rates at the project site, reported at 3% over the last quarter, 
are believed to be due to many behavioral factors. By educating the providers in the 
multispecialty clinic, I provided an urgent and informative state of the need for HPV 
vaccination and listed facts related to possible side effects. Many attitudes and personal 
biases exist in the vaccination discussion, and educating providers using an evidence-
based framework demonstrated ways to limit bias in approaching the topic of vaccination 
with eligible preteens and their parents. Therefore, educating the providers on the facts of 
HPV vaccination, risks, benefits, and indications has in turn equipped them to have the 
same impact when discussing the topic with patients and result in higher vaccination 
recommendation rates.  
The practice-focused question for the DNP project was, will education of primary 
providers increase knowledge and recommendation rates for pre-teen vaccination of HPV 
at a multidisciplinary clinic? By surveying the providers within the practice group, the 
advanced practice nurse identified perceived barriers to vaccine recommendation. The 
barriers identified within the presurvey were guided by Pender’s HPM. The rates of HPV 
recommendation were measured before and after the education in-service, and I observed 
whether a correlation exists between education and recommendation rates in the provider 
group for their preteen patients.  
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DNP-prepared nurses are especially equipped to translate the research into 
practice-related change. By searching appropriate peer-reviewed sources for defined and 
approved frameworks, the advanced practice nurse drives quality in care delivery. I 
identified the multispecialty site for the project because the large numbers of 
multispecialty providers and eligible patients and the opportunity to apply the evidence 
for recommendation during patient visits. A medical director provided oversight the 
project and the nurse vaccination champion will deliver data on rates for vaccination 
recommendation. I obtained and secured clinic data through the vaccination champion 
and clinic visits occurred on three separate occasions over a period of 6 weeks. 
Sources of Evidence 
The search engines and databases used for an educational framework on 
vaccination recommendation improvement project included CINAHL, MEDLINE, 
ProQuest, and OVID Nursing Journal review. Search terms included HPV vaccination, 
adherence, vaccination surveys, education, primary provider, advanced practice nurse, 
nursing model and theories, health promotion, advocacy, lack of access, and 
immunization barriers. I conducted the literature search in 2019 with inclusion factors of 
articles published in peer-reviewed academic journals from 2014 through 2019. Boolean 
operators were AND provider education OR immunization barriers under the topic title of 
HPV vaccination recommendation. Exclusion criteria were publications from books or 
articles focused on vaccination in general terms outside of HPV. Articles written outside 
of the English language were also excluded. A total of 417 articles were located and 35 
were used after a completion of a literature review matrix (see Appendix B). 
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Cole et al. (2017) assessed barriers to HPV vaccination and developed strategies 
to overcome them through education using the HPM. Using a mixed methodology 
interviews, surveys, and teaching points within the provider, patient, and parent 
population, the researchers measured a response to vaccination as a preventative measure 
and directly measured the effects of vaccination strategies on HPV infection rates (Cole 
et al., 2017). Results showed improved vaccination rates among centers with developed 
education methods for delivery of care (Cole et al., 2017). Evidence demonstrated that 
continued studies were needed to identify the cost effectiveness of using interviews and 
surveys as tools compared to treating HPV infection (Cole et al., 2017). The study is 
directly aligned with the DNP project study as it provides a framework for continuation 
in assessing how education impacts the rate at which HPV vaccination is being 
recommended among eligible patients.  
Senkomago et al. (2017) performed a worldwide evaluation of HPV vaccination 
strategies and surveillance of screening methods as it relates to preventing HPV-related 
cancers. The researchers wanted to have a global lens into the problem of HPV and 
enlisted the help of the WHO and the Pan American Health Organization (PAHO) to 
provide recommendations on vaccination and screening. The role of nurse was noted as 
synonymous with caring and education around the world in areas of cervical cancer 
screening. Placing the nursing professionals at the forefront of education made them a 
crucial part of the Workforce Development team to help address disparities in cancer 
related HPV prevention strategies. Despite rural and low-income countries having lack of 
access barriers, the Global Initiative for Cancer Registry Development has a goal to reach 
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150 countries participating in advocacy and collaboration networks. HPV has been 
identified as the cause for nearly all cervical cancers, some of the vaginal cancers and 
most oropharyngeal cancers around the world (Senkomago et al., 2017). As HPV 
infection and related cancers are continuing to climb, global initiatives for surveillance 
and vaccination are becoming a priority (Senkomago et al., 2017). The DNP project is 
supported by the article because it demonstrates the need for education on vaccination 
through inter collaboration and advocacy efforts described in the project. 
A systematic review article on policy changes in vaccination may be the most 
imperative strategy against the barriers of lack of access, parental social concerns, and 
bias within providers during vaccination visits (Haddad, Allen, Szkwarko, Forcier, & 
Paquette, 2018). Policy changes may support reducing or eliminating parental consent for 
vaccination, such as in Title X Authority, which enables teens to obtain oral 
contraceptives without parental consent, and would also promote school system 
involvement in vaccine administration at schools to be all inclusive of Tdap, flu, 
meningitis (Haddad et al., 2018). Concerns from parents such as “My daughter is too 
young to need the vaccine” or “The vaccine promotes early promiscuity” are addressed 
through policy support within the Title X Authority that reports it recognizes the 
“importance of confidential and preventative reproductive health to all adolescents” 
(Haddad et al., 2018, p. 13). The DNP project evaluates for barriers within the provider 
population and is supported by the article because the researchers describe how barriers 
to recommendation may be overcome if providers focus discussion around cancer 
prevention rather than sexual transmission and activity. 
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A mixed methods study evaluated the 15-year trends of cervical and 
oropharyngeal cancer, finding that as a result of screening and vaccine the cervical 
cancers have declined, but oropharyngeal cancers have continued to rise (Sussman et al., 
2015). A clinician questionnaire was used to survey external factors and barriers that had 
potential influence on vaccination adherence. Sociocultural behaviors, media and policy 
were evaluated, and providers reported a variety of challenges to vaccination 
recommendation. It was found that only 9% of eligible adolescents received complete 
series to vaccination. Recommendations included a set of counseling strategies for 
overcoming identified barriers to vaccination recommendation. Researchers found that 
the results of this study were consistent with other recently published qualitative research 
studies (Sussman et al., 2015). Clinicians who focused on cancer prevention rather than 
sexual activity counseling had a stronger adherence to vaccination. The article supports 
the DNP project efforts to encourage provider recommendation by reporting the scientific 
state of urgency behind rising infection and related mortality. The project provides a 
scientific and statistical education on the state of HPV to educate providers and translate 
evidence to practice. 
Niccolai et al. (2018) held structured interviews in 2015 with 32 clinicians using a 
thematic approach to evaluate the social impacts and barriers to HPV vaccination 
recommendation. It was found that a strong recommendation from a provider was highly 
motivating for the parent and patient in terms of vaccination adherence. Many of the 
providers surveyed reported a lack of urgency to recommendation. Emergent themes 
were identified from the questions that were asked in the interview on whether the 
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vaccine should be a mandate to healthcare or school attendance. Answers demonstrated 
that a lack of requirement status had an important influence on providers 
recommendation. Clinicians reported “it was not required for school, but we recommend 
it”, “if we could start with here’s the HPV vaccine. It’s required prior to ninth grade” and 
“That type of policy would help us.” Because the DNP project is directly surveying the 
provider population for barriers to recommendation for HPV vaccine this article serves as 
a direct example of how emergent themes within social barriers exist. The mid-range 
nursing theory in Pender’s Health Promotion Model was chosen as the projects 
framework for relating perceived social barriers into a care model evaluation. 
A mixed method study was performed with the goal of examining the parental 
and health system barriers to HPV vaccination (St. Laurent et al., 2018). The two most 
reported reasons from parents on withholding vaccination from children were lack of 
knowledge and lack of recommendation from their provider. The health system barriers 
most frequently reported were lack of access and cost for series of vaccine (St. Laurent et 
al., 2018). St. Laurent et al. (2018) researchers explain how non personal barriers may 
also hold a role in lack of recommendations for vaccines. The DNP project is evaluating 
how barriers of all personal or non-personal factors influence behavior and the article 
gives support to addressing lack of access and cost in its assessment on the urgency 
statement. 
 Clinics with specialty providers have an inter collaborative approach and are 
increasingly likely to appoint vaccine champions, use standardized policies and schedule 
appropriate time to visits scheduled for vaccination (Lollier, et al., 2018). Evidence 
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supports a systems-process-outcomes evaluation because HPV is not a reportable disease. 
The CDC has an approved self-survey module for providers that has 5 questions on the 
epidemiology of HPV that will examine the providers’ knowledge base of HPV and 
vaccination data that follows the CDC recommendation (Vaccines CDC, 2019). While 
the eligible age for HPV vaccine is 9-45 years, the CDC recommends that a two series 
vaccine be given at least 6 months apart to 11 and 12-year-old children. Data shows that 
two series vaccine protects best if received before age 15 or before sexual activity has 
started (CDC, 2019). Scientific data on the current state of national and global infection 
rates supports the translation for the DNP project. The urgency statement will be created 
from the most current data. The article provides scientific terms of when to deliver a 
vaccine recommendation and sets the evidence-based care template for which the 
providers in the project will make recommendations. 
The American Cancer Society addresses the problem of poor provider vaccination 
rates/recommendations by working as a direct partner in health initiatives and program 
development in collaboration with CDC. A new set of initiatives have been created and 
approved with new goals for vaccination of HPV focusing on reaching 80% adherence by 
2026 (Fedewa et al., 2018). The HPM considers how behavioral factors within the 
provider population affects whether the provider makes the recommendation to vaccinate. 
Providers may have their own personal beliefs or opinions that present as barriers to 
recommendation for HPV vaccine. Pender’s HPM applies theory to address the 
disparities in health between males and females in receiving HPV vaccination. Lack of 
access to care is a barrier that plays an environmental impact depending on geographic 
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area lived when it comes to continued exposure to HPV and level of recommendation 
(Healthy People, 2020). The overarching theme for the DNP revolves around evaluation 
of how education may improve recommendation rates for HPV vaccination. With the 
national guidelines remaining consistent in encouraging providers to overcome barriers to 
reach 80% adherence, the article gives support to the project framework. 
Evidence Generated for the Project 
Participants 
The participants within the multispecialty clinic have certifications in family 
practice, internal medicine and pediatrics. There are 21 providers in the clinic composed 
of seven nurse practitioners, eight physicians’ assistants and six medical doctors. The 
clinic also benefits from the service of a full-time nursing care directive that encompasses 
10 nurses and 1 nurse champion for vaccines. The providers maintain certification 
through their respective certifying agencies and are in good standing under the licensing 
boards. The practice is located centrally within the large rural community and serves as a 
referring health system to over 12 major hospitals in the area. The practice area is in a 
community in the Mid-Atlantic United States serving over 465,000 people within a 60 
miles radius with an estimated 69,750 of those individuals being aged 6-18 years (Census 
Bureau, 2018). The clinic identifies itself as a multifaceted Christian based affiliate for 
healthcare. 
Procedures 
The medical director provided oversight in the process in which the nurse 
champion will provide vaccination data on how many vaccination deliveries occurred 
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from participating providers in the month prior to my initial visit for pre-assessment. The 
champion had access to an electronic data base in which she obtained data specific to 
HPV vaccinations in children ages 11-15 years old and provided the information as 
deidentified data. The nurse champion created and then printed the deidentified 
worksheet for me when I arrived.  
The pre-education survey titled “WD4019: You Are The Key to HPV Cancer 
Prevention-2018” is a brief assessment tool that includes 5 multiple choice questions 
adapted from the CDC’s online CE module that will take approximately 5 minutes to 
complete (see Appendix A). The questions evaluate the providers’ knowledge base on the 
current statistics of HPV infection and evaluates behavioral barriers that discern 
perceived or actual barriers to recommendation for the vaccine. The vaccination 
champion delivered the survey to the providers while they work at the centralized nursing 
station. The providers completed the paper and pencil survey between patient 
evaluations. Providers consented to participate in the project with the completion of the 
anonymous survey. After the providers completed the survey, they gave it to the nurse 
vaccine champion who placed it in the envelope labeled “Pre-Education Survey”. The 
nurse champion placed the completed surveys in a locked file cabinet within her private 
office. 
I evaluated the data report provided by the nurse champion to compare the 
recommendation rate at the clinic for the HPV vaccine and related adherence rates to that 
of national CDC goal of 80% vaccine adherence. The results from the pre-education 
survey were reviewed within the nurse champion’s office and kept secure in the locked 
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cabinet until project completion. The survey was used to identify specific barriers to 
recommendation and matched with statistical information regarding the scientific state of 
the HPV vaccine. For example, the providers answered that lack of recommendation 
comes from parental fear about possible adverse reactions from the vaccine, I placed 
information on the urgency statement that provides an evidence-based response to 
adverse reaction rates with the vaccine. The use of the evidenced- based literature 
provides support to each identified barrier. 
To develop the urgency statement, a literature review was conducted using the 
Boolean operators AND provider education OR immunization barriers under the topic 
title of HPV vaccination recommendation. Inclusion criteria included articles with key 
search terms on provider education, statistics on HPV infection and vaccination 
recommendation strategies. The articles included provided support to the provider 
education model used in the DNP project and be dated between the year 2014- 2019. 
Exclusion criteria are articles that focus on vaccinations for other diseases that weren’t 
HPV. Articles written in languages other than English were excluded. A literature review 
matrix was created and used to evaluate the literature. The urgency statement was a one-
page statistically significant information sheet on the facts about HPV infection, 
vaccination risks and benefits to vaccination adherence. The urgency statement on HPV 
was aligned with support from the literature with suggestions on how to increase rates of 
vaccination recommendation. The medical director was identified as the practice 
representative and was responsible for reviewing the in-service materials and the urgency 
statement before delivery. 
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Visit number two occurred 1 week after the pre assessment visit. The providers 
working attended an educational in service in the clinic breakroom and were given a copy 
of the urgency statement to use a guide over the next month in their clinical practice. The 
educational content from the urgency statement was delivered to the providers and the 
nurse champion in the centralized breakroom in the clinic. Using a poster, I presented the 
findings from the pre survey and the current data on the HPV virus, vaccines and barriers 
as they were identified on the survey in an open discussion format. The providers also 
had an opportunity to ask questions during and after the in service. The providers were 
able to reach me via email if they have questions regarding vaccination recommendations 
or over material presented in the in-service for a month post education. The vaccine nurse 
champion also had my contact information. The education phase occurred over a four-
week period. 
Visit number three occurred 5 weeks after the delivery of the urgency statement. 
During the post education visit I returned to the clinic to give the post education survey 
titled “WD4019: You Are The Key to HPV Cancer Prevention-2018” to the nurse 
champion who delivered it to the providers to complete in the centralized nurses station. 
The providers completed the paper and pencil survey between patient evaluations. 
Providers consented to participate in the post survey with the completion of the 
anonymous survey. Providers completed the de identified surveys and returned them to 
the nurse champion who placed the surveys in an envelope titled “Post-Education 
Survey” and returned them to me during my visit. The results from the post education 
survey were reviewed within the nurse champion’s office and kept secure in the locked 
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cabinet until project completion. The vaccination champion pulled the vaccination 
provider recommendation percentages from the electronic record database and printed the 
report without patient protected information. The champion placed the report in a 
separate envelope marked “Vaccination Recommendation Report”. All the data was kept 
deidentified and secured in the private office of the nurse champion. Review of results 
occurred inside the nurse champions office only. None of the data sheets, surveys or 
vaccination reports were removed from the secured office at any time. The data was 
transferred to an electronic spreadsheet that was password protected and encrypted to 
examine the breakdown of which barriers were chosen and all paper documents were 
shredded. 
Instruments 
The National Committee of Immunization and Research (NCIR) and the ACIP 
have defined evidenced based guidelines for HPV vaccination that the CDC used to 
create the module (Health and Human Services, 2019). The CDC has a wide scope 
initiative for HPV vaccination and program that includes references and tools for 
clinicians contained in the HPV Toolkit and has an assigned approved Office of 
Management and Budget (OMB) # 0990-0379 expiration date 9/30/2020 (Health and 
Human Services, 2019). The tool  titled “WD4019: You Are The Key to HPV Cancer 
Prevention-2018” included five major item sections of content that measures learning 
objectives in the areas of HPV vaccine as cancer prevention, indications for the vaccines 
in boys and girls, components of vaccine recommendations, relevant and compelling 
information on the vaccine for parents, and disease prevention risks and strategies 
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(Health and Human Services, 2019). The tool was reviewed by the ACIP and placed in 
the Morbidity and Mortality Weekly Report in February 2019 (Vaccines CDC, 2019). 
The tool was approved for Continuing Nursing Education credit by the American Nurses 
Credentialing Committee in April 2018 (ANCC) (Vaccine Education, 2018). The U.S. 
Department of Health and Human Services and the ACIP references the tool throughout 
the research and literature on HPV vaccination (Vaccine Education, 2018). There is no 
information listed regarding the instrument’s reliability. 
Protections 
The project protects participants with the completion of human protection training 
completion, CITI certification and Walden IRB. Walden IRB form A was completed and 
submitted to be kept on file through the university. Systems used for recording and 
tracking data for the DNP project included data retrieval from the electronic record 
medical obtained by the vaccination nurse. Anonymity to the partner site name and 
location was maintained along with ethical standards for the DNP project. Consideration 
of barriers to vaccination included behavioral factors, and Pender's Health Promotion 
Model to consider individual experiences, perceived benefits, barriers, interpersonal 
influences, competing preferences and activity related affects to assimilate and develop 
an urgency statement will be used. Positive behavioral effects include early and 
appropriate access to vaccination age, therefore promoting full vaccination with just two 
injections instead of three, discussing cancer prevention and promoting health behaviors 
in adolescents and opening a dialogue about other sexual health behaviors and pregnancy 
prevention as well (Holman et al., 2014). 
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Analysis/Synthesis 
The nurse champion recorded only the numerical percentages of the vaccination 
adherence rates at the clinic and kept the report stored securely in her office until I 
arrived to compare those percentages to eligible office visits. Statistical methods for 
evaluation included a t-test to compare the pre-education vaccination recommendation 
rates with the post education vaccination recommendation rates. However, the use of a 
correlation coefficient was not used to measure strength and direction between provider 
perceived barriers and recommendation rates as they independent variable of the study 
were not constant.  
Analyzing and maintaining deidentified statistics was done on a Microsoft Excel 
spreadsheet. By using descriptive statistics to summarize the data placed in the 
spreadsheet I was able to measure whether the staff education model had meaningful 
impacts toward vaccination recommendation. Each answer chosen was counted and 
totaled on the spreadsheet. Answers from the pre assessment survey were used to 
calculate a total number of times it was chosen out of the total surveys received. The data 
from the vaccination recommendation reports and the pre-education surveys helped to 
define what urgency statement statistics were placed into the final urgency statement to 
be delivered during the in service. 
The practice focus problem of poor vaccination recommendation was evaluated to 
discern if education through an in-service on the urgency of HPV vaccine improved 
vaccination rates. After the in-service, the results were reviewed to count how many 
times a survey answer was chosen. The pre survey and post survey responses were not 
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evaluated by a correlation coefficient to determine how barriers chosen compared with 
provider vaccination recommendation rates. 
The evidence justifies HPV vaccination as an imperative importance to the 
nursing profession (Vaccines CDC, 2019). Assessing behavioral factors in healthy and 
non-healthy individuals is a key role for a professional nurse, as is the ability to help 
patients maintain health through educational measures or framework. When assessing 
how behavioral factors such as perceived risks and benefits to vaccination are relayed 
from provider to patient, Pender’s Health Promotion Model provided the framework in 
which to base recommendations for change. As an in-service related staff education 
project, measured outcomes to improve patient care and achieve standards of practice 
was a part of the framework and program objectives for this clinic and will include 
identifying the programs’ impact on social change. In order to analyze or assess quality in 
healthcare outcomes advanced practitioners consider the terms of restoring function and 
survival within the target group (Donabedian, 2005). The Donabedian Model is a three-
pronged assessment in which the limitations must be described in relation to measured 
outcomes. 
Summary 
The purpose of this project was to demonstrate that primary providers have a 
direct and positive influence on HPV vaccination adherence through recommendation. 
In-service and urgency statement delivery reduced barriers and close the knowledge gap 
for providers responsible for HPV vaccination. Because HPV is a sexually transmitted 
infection, the healthcare provider focus should be on education regarding cancer 
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prevention to necessitate adherence. Vaccination administration rates at the project site 
initially reported were 3% and were believed to be due to many behavioral factors. The 
practice-focused question for the DNP project was, will education of primary providers 
increase knowledge and recommendation rates for pre-teen vaccination of HPV at a 
multidisciplinary clinic? By surveying the providers within the practice group, I 
anticipated identifying perceived barriers to vaccine recommendation. The rates of HPV 
recommendation were measured before and after the education in-service and I observed 
whether a correlation was appreciated between barriers and recommendation rates in the 
provider group for their pre-teen patients. The search engines and databases used for an 
educational framework on vaccination recommendation improvement project included 
CINAHL, MEDLINE, ProQuest, and OVID Nursing Journal review. 417 articles were 
located and 35 were used after a completion of a literature review. The literature review 
matrix was developed using the 8 major articles that supported the DNP project evidence 
on education toward vaccination. The project was carried out over a 6-week timeline and 
included oversight and approval from the practice medical director. Protections were 
made to ensure ethical standards and privacy by de identifying all three instruments in the 
project and the clinical site itself. Data was reviewed on site in the nurse champions 
private office space. All surveys and data collected were placed in an envelope and 
secured in a locked cabinet within the nurse champions private office. A statistical 
analysis with t-test comparisons between pre and post education groups was evaluated as 
well as the overall rate for HPV vaccination recommendation among the provider group. 
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Section 4 of the proposal discusses the findings and conclusions of the DNP project and 
reflects on the strengths and limitations of the project as it was implemented. 
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Section 4: Findings and Recommendations 
Introduction 
The CDC established the Healthy People 2020 initiative for HPV vaccination 
uptake of 80% in effort to effectively eliminate HPV-associated cancers (Vaccines CDC, 
2019). Both men and women are being diagnosed with HPV-related cancers despite 
health care initiatives and provider awareness campaigns. Locally, the public 
commissioner of health and the CDC have reported that while national HPV vaccination 
rates among eligible adolescent patients are recorded at 40%, our state records an even 
lower vaccination uptake of 30% (HPV Vaccines, 2018). The problem of HPV infection 
is reaching 45% of the U.S. population and is anticipated to grow if states do not react to 
find vaccination compliance strategies (HPV Vaccines, 2018). Because the local region 
had demonstrated poor vaccination recommendation rates, the problem focus within the 
project was on assessing barriers to recommendations for prescribing the HPV 
vaccination within the primary provider population.  
Conducting a vaccination adherence project in a multidisciplinary clinic increased 
the feasibility of vaccination, as these clinics have certified family practice, internists, 
and pediatrician providers. The gaps in practice have been confirmed through the Pre-
Education Survey titled the “WD4019: You Are The Key to HPV Cancer Prevention-
2018.” Any decrease in vaccination adherence has a direct and inverse effect on increased 
risk for transmission of the disease (Capps, 2019). The practice-focused question for the 
identified problem of poor HPV vaccination rates was, will educating primary providers 
in a multidisciplinary clinic on the current state of HPV result in increasing HPV 
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vaccination knowledge and recommendations for vaccination of eligible pre-teens to 
80%? The objective was to determine if education of primary providers would increase 
knowledge and recommendation rates for preteen vaccination of HPV. Section 4 presents 
the findings, implications, project team contributions and limitations that were made 
evident as a part of this quality improvement project. 
Findings and Implications 
The purpose of this quality improvement project was to provide multispecialty 
providers an evidenced based educational urgency statement on the current state of HPV 
infection and complete an assessment of barriers related to recommendation to 
vaccination in clinical practice. The framework of Pender’s HPM was compelling toward 
creating evidence-based change as the framework promotes self-evaluation of perceived 
and actual barriers in health. The DNP project began with an assessment of how one 
multispecialty practice may improve their recommendation toward HPV vaccination after 
an education in-service and an urgency statement on HPV facts. The clinic has 21 
multispecialty providers, including internal and family medicine physicians, 
pediatricians, nurse practitioners and physician assistants. The project included a review 
of the current HPV vaccination recommendation rate at the site and a pre-education 
survey that assessed the barriers to recommendation among the provider group. I 
developed the urgency statement for education in poster format for the in service after the 
data from the vaccination report and pre survey was evaluated. The urgency statement 
was developed by using the literature review matrix and the CE Module from the CDC 
(Vaccine Education, 2018). 
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Pre-Education Collection of Vaccination Data  
Retrospective data from the electronic medical record (EMR) were collected by 
the vaccine champion for the month prior to project initiation to determine how many of 
the in-office adolescent visits resulted in provider recommendation of vaccination for 
HPV. The nurse champion provided the Pre-Vaccination Data Report to me for review in 
her office after she created a report by identifying the meaningful use checkboxes for 
HPV discussion in the electronic record. The providers would document their discussions 
on HPV vaccination with patients and parents by using the check box system. The nurse 
champion entered the key term “HPV” into the EMR to obtain the report for the 4-week 
period prior to the in-service. The report revealed that there were 808 adolescent visits of 
which 28 showed HPV vaccination recommendation through the checkbox system. The 
baseline vaccination recommendation rate for the clinic during in office visits was 3% 
(see Figure 1). Figure 1 shows the number of visits and recommendation rates for HPV 
eligible teens from the month prior to the project start date. The total recommendation 
rate did not consider the vaccine clinic visits if they were not associated with an in-office 
visit. The clinical site operates an independent vaccine clinic that does not track 
documentation check boxes on recommendations therefore the vaccine clinic visits were 
not included in reported vaccination data. 
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Figure 1. Multispecialty clinic visits and recorded adolescent visits with recommendation 
towards HPV at baseline.  
 
As the DNP team leader, I transferred all data from the vaccination data report 
into a password-protected Excel spreadsheet. The baseline data report represents the total 
number of in-office visits, eligible teen visits, and total number of recommendations for 
HPV for the clinic over the 4 calendar weeks prior to the initiation of the project (see 
Table 1). The total number of monthly in-office visits for the clinic was 1,816 of which 
the number of eligible teen visits were 808. Twenty-eight of the 808 teen visits had a 
check box marked in the EMR representing a 3% recommendation rate for HPV 
vaccination.  
97%
3%
HPV Vaccination Recommendation Rates
Adolescent visits
Adolescents receiving
recommendation
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Table 1 
 
Number of In -Office Provider Recommendations for Eligible Adolescents at Baseline 
Visit type Patient visits (over 4 weeks) Percentage 
Monthly patients  1,816  
Eligible teen visits 808 45 
Visits with HPV vaccine 
recommendation 
28 3 
 
Pre-Education Survey 
Visit 1 occurred October 28, 2019 and marked the start of the project. The Pre-
Education Survey was distributed by the vaccine champion to the nine providers on staff 
for patient care during that day. The vaccine champion placed the completed surveys in 
the Pre-Education Survey envelope and filed the surveys in her locked, private office for 
my review on site. The pre-education survey did not contain provider identifiers or 
patient information in order to maintain security and prevent bias in interpretation.  
The providers were administered a Pre-Education Survey on the potential barriers 
to recommendation using a validated CDC tool and CE module titled” WD4019: You 
Are the Key to HPV Cancer Prevention-2018” (see Appendix A). The survey responses 
identified adverse reaction concerns and knowledge deficit as the largest barrier to 
recommendation (see Figure 2). Barriers of parental “anti vax” philosophy, parental 
consent, and religion were rated the same. 
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Figure 2. Pre-education survey on provider barriers to recommendation. 
 
I used the barriers of parental consent, anti-vax philosophy, and concerns about 
adverse events to create the urgency statement as they were identified as the perceived 
most common provider barriers on the Pre-Education Survey. Of the nine providers 
present on visit 1, seven completed the pre-education survey. The barrier of religious 
affiliation was not directly addressed on the urgency statement outside of simply 
reporting that it may be cause for exemption within some parental groups. 
Development of Education and the Urgency Statement 
A literature review was conducted using the Boolean operators AND provider 
education OR immunization barriers under the topic title of HPV vaccination 
recommendation for the years 2014-2019. Inclusion criteria included articles with key 
search terms related to provider education, statistics related to HPV infection and HPV 
70%
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Provider Barriers to HPV 
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vaccination recommendation strategies. The search engines and databases used to 
develop the educational framework for the HPV vaccination recommendation 
improvement project included CINAHL, MEDLINE, ProQuest, and OVID Nursing 
Journal review. Exclusion criteria were articles that focused on vaccinations for diseases 
other than HPV and written in languages other than English. Of the 417 articles that were 
located, 35 were used as references for the project. The literature review matrix was 
developed using eight articles that supported the DNP project evidence on education 
toward vaccination. The eight articles included on the matrix were chosen specifically 
because they reviewed existing education frameworks in schools or health centers 
making them applicable evidenced based support references for the DNP project.  
Knowledge gaps related to adverse reaction potential were also identified in the 
provider group specifically regarding cancer occurrences related to HPV infection for 
boys as compared to girls. The urgency statement was created by matching education key 
points and objectives from the CE module from the CDC with the key findings on 
adverse reactions from the literature review matrix (Appendix C). The five objectives on 
the urgency statement aligned key concepts from the CE module from the CDC 
including, understanding how the clinics adherence rate aligns with the CDC healthy 
people 2026 goals on the indication for HPV vaccination in cancer prevention, explaining 
how to implement disease prevention strategies, such as bundling school aged vaccine 
recommendations, providing information to parents on the indications and safety profile 
on HPV vaccine, providing knowledge that HPV causes cancers in girls and boys 
including cervical, oropharyngeal, vaginal, penile, and anal cancers, and lastly explaining 
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components of effective recommendation and timing to vaccination (Vaccine Education, 
2018). 
Education Framework 
Visit two occurred on November 4, 2019 during the second week of the project. 
At this time, the urgency statement was delivered in poster format. The poster was 
displayed in the general provider break space and I was available for questions. The 
medical director requested that there not be formal stop care meeting or in-service. The 
providers would independently come by the break room and review the poster as they 
were able on any workdays over the next four weeks. Because the providers on staff had 
limited time to spend with me during the in service and urgency statement delivery the 
medical director met with individual providers to give a review of the urgency statement. 
I was unable to ensure the information was delivered to each provider with a serious tone 
and sense of urgency due to the limited time and exposure I had with individual 
providers. The program design was that I would hold a brief conference collectively for 
providers on the second visit, which I was not given the opportunity to do. However, the 
gaps identified in visit one on the Pre-Education Survey were consistent with the gaps 
found in the literature from projects done in similar educational design. Along with 
barriers the providers surveyed on visit one also identified a gap in HPV cancer 
knowledge, therefore, the information used in creation of the urgency statement was 
appropriately aligned to close gaps and overcome bias. Suggestions for ways to address 
the areas of weakness to recommendation were described on the urgency statement. 
Providers would be left to review the urgency statement on their own accord during their 
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working timeline. The medical director explained that only nine of the 21 providers were 
on staff the day of project visit two, and because not all the providers employed at the 
clinic would have opportunity to hear the in service and education on HPV, that he would 
directly review the information with all of the providers. I provided a detailed in service 
on the HPV urgency statement and poster to him as the overseer of the clinic site and the 
vaccine champion placed the poster on the wall in the provider break room at that time. 
Post Education Survey 
After 4 weeks of project implementation, the third and final visit for the DNP 
project was December 2, 2019. The Post Education Survey was delivered through the 
nurse vaccine champion to the providers in the clinic providing in office visits that day. A 
total of five providers worked in the clinic this day with only four completing surveys. 
The four de identified surveys were collected by the vaccine champion and placed in the 
secure envelope titled “Post Education Survey”. The vaccine champion provided the 
surveys for my review in her private office. Upon review of the data from the surveys I 
recorded that three out four providers (75%) identified that adverse reactions from HPV 
vaccine and the knowledge regarding how to handle those questions was the largest 
barrier to recommendation (Figure 4). Concern regarding adverse reactions was the 
largest perceived barrier in the Pre-Education Survey responses as well. The anti vax 
philosophy was the only other perceived barrier for the post education group of providers, 
with two out four (50%) reporting anti vax philosophy as a barrier to recommendation. 
The pre-education barriers of parental consent and religion were not appreciated in the 
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post education survey group. As the DNP project leader, I transferred all deidentified data 
onto a spreadsheet on site before documents were shredded. 
 
Figure 4. Post education survey on provider barriers to recommendation. 
Post Education Collection of Vaccination Data 
The Vaccination Data Report was printed by the nurse champion from the EMR 
and kept secure in her locked, private office until my review. Once the providers 
discussed HPV vaccination with the patient and parent, they were responsible for 
checking the checkbox associated with in office education on HPV noting criteria was 
met and project tracking was initiated. Over the four-week period from the date of 
urgency poster delivery the total number of eligible visits and corresponding visits with 
checkboxes marked were included in the report. The vaccination data report revealed a 
100% vaccination recommendation rate for the post urgency in service time period (Table 
60%
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2). Table 2 represents the total number of in office clinic visits, eligible teen visits and 
teen visits recorded with HPV recommendations for the four weeks since urgency 
statement delivery at the clinical site. The total number of in office adolescent visits for 
the post education month were 1,155. Of the 138 teen visits all 138 visits had recorded 
recommendation toward HPV vaccination as evidenced by check box tracking. Because 
this four-week time period was over a holiday week and less providers were seeing 
patients, the total number of eligible patient visits were reduced compared to the baseline 
data report. 
 
Table 2 
 
Number of In-Office Provider Recommendations for Eligible Adolescents During Post 
Urgency In-Service Time Period 
Visit type Patient visits (over 4 weeks) Percentage 
Monthly  1155  
Eligible teen visits 138 12 
Visits with HPV vaccine 
recommendation 
138 100 
 
The recommendation rates were collected for the month prior to project initiation 
and then again collected during the one-month post urgency delivery for comparison 
(Figure 3). The baseline total monthly visits for adolescents were recorded much higher 
than the post urgency statement month. The discrepancy between recorded number of 
office visits pre and post project was believed to be due to a modified holiday schedule in 
November. Also, it is important to note the baseline month was a school start month and 
the clinic schedules a high number of school start visits for physicals and vaccines as 
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required by state and school health mandates. Recommendations to vaccinate have been 
identified as the most significant predictor of vaccination adherence among the pre-teen 
population, demonstrating how a provider focused project will create social change 
(Niccolai et al., 2018).  
Figure 3. Multispecialty clinic recorded adolescent visits with recommendation toward 
HPV in the pre and post urgency project period. 
 
Summary of Findings 
There was a statistically significant improvement in the rate of recommendation 
for HPV vaccination after urgency statement delivery at the project site. The baseline 
recommendation rate for the site was based on check box documentation on HPV and 
was close to 3%. After education reassessment of the vaccination data for the four weeks 
post education and urgency statement delivery recommendation was documented at 
100% for the in-office clinic visits. The increase in monthly recommendation was 82 
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additional recommendations or a 292% increase when comparing the post education time 
period to the baseline rate. The project objective was to measure the rate of provider 
recommendation toward the HPV vaccine for one month after urgency statement delivery 
and show a quality improvement in practice.  
Recommendations 
Individual Stakeholders and Policy 
Stakeholders for the DNP project included providers, parents, and adolescents. 
Indirect stakeholders are the policy makers involved in creating solutions toward change 
regarding vaccinations. While evidence toward HPV vaccination effectiveness is 
deliberately sent to the public through media and trusted healthcare journals, providers 
continue to demonstrate barriers to recommendation of HPV vaccine. Ways to address 
the lack of access, associated costs of vaccination adherence and knowledge gaps on the 
topic of HPV are delivered to the mainstream public but do not always create buy in. 
With the anti vax movement in America and continued increase in rates of HPV-related 
cancers, it is imperative that policy makers get involved in legislation toward change. 
Healthcare policies work to allow for a concerted equal effort between state and federal 
agencies to promote safety and quality while managing the cost to afford achieving and 
maintaining of the vaccination adherence goal (France, 2008). The problem with the idea 
of federalism is the cost structure. While federal support is gained through CMS at a 
higher rate than what is expected of states, the idea of weighted control doesn’t always 
fall into the hands of the federal entity. States are still very much in a fight to control 
decisions that are often deliberated on by the federal government when they individually 
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feel a loss of sovereign right to oppose any such policy (France, 2008). For example, the 
Patient Accountability Act was implemented with a fee if individuals chose to forego the 
purchase of health care, but states were quick to refute the fee and the demand for 
coverage (France, 2008). Current policy funding for vaccinations is supported by the 
CMS at a rate of 65% from federal sources and the remaining needs for cost coverage 
must be met by state taxpayers (France, 2008). Proposals have been made to increase the 
federal support from 65% to 72% but does not consider more control in decisions to 
practice (Medicare and Medicaid, 2015). To specifically appeal stakeholders to cost 
effective strategies, policies on HPV vaccination aim to consider as many state 
representatives as possible, I have met with my state senators and representatives to 
collaborate on solutions. The priority solution purposed is one that is feasible and 
measurable focusing on the creation of state legislation that supports the addition of HPV 
vaccination recommendation on physical examination forms for middle school aged kids. 
By implementing verbiage on recommendation into tracking EMR systems for providers, 
legislative measures may also encourage documentation of discussions with adolescents 
and parents. Other considerations include removing parental consent, implementing 
school programs or mandates, tightening vaccine exemption language, and expanding 
federal initiatives, such as Title X Authority, for adolescents (Orenstein & Yang, 2015). 
While the purposed solutions have potential to impact vaccination adherence, there is no 
one solution to creating buy in among stakeholders. The largest impetus remains 
education. The DNP project site currently uses physical forms that have been approved 
for reprinting and education from the American Academy of Family Physicians, The 
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American Academy of Pediatrics, the American College of Sports Medicine and the 
American Osteopathic Academy of Sports Medicine 2010 version #CI-191D (5/12). 
While the physical examination forms do not currently include any recommendation 
toward age appropriate vaccines, State Senator Dr. Richard Briggs proposes to add HPV 
vaccination recommendation to the physical examination forms. Other stakeholders to 
consider in policy advancement toward HPV vaccination recommendation would be the 
school board directors and the states medical association president for support.  
Leading the way for advanced nurses, the American Nurses Association (ANA) is 
also a prominent leader in community health and advocacy. The ANA has endorsed the 
recommendation from the Expert Panel of Emerging Infectious Disease on the 
recommendation for the use of vaccines for disease prevention (American Academy of 
Nursing, 2014). CE nursing modules toward education on vaccine awareness and disease 
prevention are available for clinician nurses from the ANA in efforts to support up to date 
standards of care (American Academy of Nursing, 2014). Most recently the ANA 
released a statement of support toward the CDC’s screening and treatment of Hepatitis C 
and is offering education for nurses and advanced providers on up to date treatment 
recommendations on both HCV and HPV (American Academy of Nursing, 2014). 
Because my state of practice remains a restricted practice state (T.C.A.63-7) and has 
made little advancement toward change in practice laws for advanced nurses in the last 
fifteen years, scope of practice legislation may become a secondary policy issue related to 
the project advancement that I pursue into my career (American Academy of Nurse 
Practitioners, 2019). The position statement from the American Academy of Nursing 
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2014 on the issue of infectious diseases and vaccination states “nurses should engage 
local, state and national leaders through advocacy and education” thereby increasing 
“awareness and access” within the communities they serve (p.372). 
Clinical Sites and Change 
The project site property has the potential to reach many eligible adolescents and 
their parents if providers would consider adding a vaccination education model to their 
walk-in and vaccine clinic. Currently the clinic does not have a formal way to track 
eligibility outside of age and the checkbox system. A check box system is not 
incorporated in the walk in or vaccine clinic that operates in conjunction with the main 
clinic. The walk-in clinic feels a duty to provide timely urgent and sick care evaluation to 
the community and does not place priority for HPV vaccination inside either of the 
ancillary clinics. However, with the numbers of potential adolescent visits occurring in 
the clinic it may be something to consider. Perhaps having a flyer on HPV to distribute at 
these visits would allow the parent to consider the vaccine on the next visit or schedule a 
visit in the vaccine clinic later. The vaccine clinic was not included in our project 
outcomes because the clinic lacked the ability to track education on HPV or 
recommendation. Currently the vaccine nurse can give vaccinations to those patients who 
call in independently for vaccination. Adding a tracking box and an educational flyer for 
both the walk in and vaccine clinic may also help the clinics move toward better 
vaccination adherence. Increasing services to more outreach and ancillary clinics may 
help to reduce lack of access to care and cost barriers by eliminating the socioeconomic 
or demographic evaluation of the adolescents only coming to routine office visits for 
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care. Feiring et al. (2015) explained how an association between parental income level 
and adherence to HPV vaccination is often noted indicating that higher income parents 
are more likely to have their child vaccination. In considering socioeconomic standing 
the provider should also consider health literacy of the parents. As an inference to income 
is often made by providers that connects income to education a careful health literacy 
review should be considered in educational intervention programs for vaccinations as 
health literacy and education do not always result in compliance of vaccination 
recommendation (Feiring et al., 2015). By placing the health professionals at the 
forefront of education, they became a crucial part of the workforce development team to 
help address disparities in cancer related HPV prevention strategies. Despite rural and 
low-income countries having lack of access barriers the Global Initiative for Cancer 
Registry Development has a goal to reach 150 countries participating in advocacy and 
collaboration networks. HPV has been identified as the cause for nearly all cervical 
cancers, some of the vaginal cancers and most oropharyngeal cancers around the world 
(Senkomago et al., 2017). As HPV infection and related cancers are continuing to climb, 
global initiatives for surveillance and vaccination are becoming a priority (Senkomago et 
al., 2017).  
Support for Additional Clinics 
While CMS and private payers are providing financial coverage at 65% of billable 
services, the federal government also focuses on evidenced based practices that reduce 
variation and are valid to translation in patient centered areas despite demographics 
(Medicare and Medicaid, 2015). Since larger financial support is delivered from the 
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federal government perhaps more control should be allotted therein and states should 
follow suit. The focus of CMS based principles strive to reduce health disparities and 
improve expansion of CMS services to all people, especially minority and vulnerable 
populations (Medicare and Medicaid, 2015). Federal support is evident in healthcare 
reform and is fostering changes we see in healthcare with the building of Accountable 
Care Organizations, giving way to transformation of primary care, integration of 
resources, payment reform, and developing strategies to measure quality (Medicare and 
Medicaid, 2015). Multispecialty provider groups such as the one in the DNP project can 
continue to work toward HPV vaccination recommendation long after the completion of 
the project. Focusing on the Hub and Spoke Initiative from the ACS helps providers hold 
each other accountable for recommendation. Reviewing the positions of other states in 
the US reveals Iowa and Rhode Island are the two states that have unrestricted access for 
adolescents under the Title X rule and have also been on the forefront of school-based 
vaccination programs and sexual education frameworks. Ruger (2008) describes how 
universal health care coverage is a crucial point to accessing high quality healthcare, as 
insurance coverage lends itself to more resources for the care needed and is a major 
economical barrier. Overall, increasing opportunities for multispecialty providers to 
recommend and deliver the HPV vaccine will help move policy forward toward 
improving adherence to vaccination but evidence suggests that providers would 
recommend more often with the backing in school entry requirement, like those policies 
that support Tdap and meningitis vaccines (Colgrove, Abiola, & Mellow, 2010). 
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Local and Global Communities 
The WHO has worked with countries on a grand scale toward HPV vaccination as 
the infection relates to 14 million new cases a year in the US alone and 570,000 
associated cancers (Altobelli, Rapacchietta, Profeta, & Fagnano, 2019). In the US we 
may believe that vaccines are evidenced based but must also consider (by state) who is 
going to fund such efforts (Eckenwiler, 2009). Barriers to vaccination in the US come in 
many forms, such as lack of access or cost or stigma. Within the US constitution we are 
presented a counterexample of perceived public health benefit and adherence (Colgrove, 
Abiola, & Mello 2010). An example of counter belief comes from the 1905 Jacobson Bill 
that describes how smallpox was eradicated. In 2006, the FDA approved Gardasil for 
girls to prevent HPV-related infection and associated cancers, and then in 2011 the 
recommendation for boys followed (HPV Vaccines, 2018). Healthcare leaders may 
address barriers to recommendation by focusing legislation efforts on development of 
vaccine policies or by incorporating stronger exemption language around several existing 
vaccine policies. Currently there are school entry mandates around the Tdap and 
meningitis vaccines that have resulted in adherence for vaccination to reach the 80% 
benchmark across the US (Perkins, Lin, Wallington, & Hanchate, 2016). Because the 
mandates have vague exemption terminology incorporated into them, parents can opt out 
of vaccination leaving the unprotected students at risk for disease transmission (Haddad, 
Allen, Szkwarko, Forcier, & Paquette, 2018). Language around existing mandates for 
school entry could be added to include HPV as a precedent for change. The exemption 
language could also be tightened to require religious clergy or medical exemption only, 
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removing the parental exemption (Orenstein, & Yang, 2015). Lastly, considerations 
toward writing expansion language around the federal Title X Authority to offset any 
discrepancy around socioeconomic standing may also aid in higher adherence to 
vaccination (France, 2008). The ACIP works with federal health agencies in developing 
the evidence to support recommendation standards and EBP practices (Colgrove, Abiola, 
& Mello 2010). After the FDA approved the use of the HPV vaccine for girls and boys, 
42 states agreed to consider mandates for HPV vaccination, but only Virginia and the 
District of Columbia ultimately adopted the mandate. Rates for adherence remained 
57.3% in girls and 34.6% in boys compared to other mandated vaccine related adherence 
rates with Tdap and meningitis of 91.3% (Orenstein, & Yang, 2014). The reason that, 
despite mandates, adherence is believed to have remained low, is the issue of loose 
verbiage around exemptions and individual rights (Perkins, Lin, Wallington, & Hanchate, 
2016). Also, it should be noted that the current two states with mandates are only directed 
to the female population in school-based programs resulting in continued low adherence 
and support (Perkins, Lin, Wallington, & Hanchate, 2016).  
The DNP prepared nurse specifically can work to increase knowledge among 
multispecialty providers such as dentists, pediatricians, PCP, NP’s, to provide screening 
and vaccine delivery. The DNP prepared nurse also should assist in developing state 
policies and consider mandates for school entry-tightening exemption language by 
becoming involved in policy (Tyer-Viola et al., 2009). Clinical practice in specialty areas 
may benefit from an educational model that stresses urgency around HPV vaccination 
and cancer prevention. The DNP nurse has a moral obligation to maintain HIPAA around 
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vulnerable populations such as the adolescent. The DNP project addresses barriers to 
access to care and improving vaccination adherence can be accomplished through 
mandates or expansions in health programs. Maintaining HIPAA privacy laws and 
promoting cancer prevention and risk behavior modification in vulnerable adolescent 
populations continues to have ethical implications toward policy development.  
Contribution of the Doctoral Project Team 
The DNP project team consisted of myself, the medical director, and the nurse 
vaccine champion. The medical director provided oversight and approval for all data 
collection procedures and education delivery methods. The vaccine champion provided 
data reports and served as a liaison between the providers and the project leader. The 
Vaccination Data Report was printed by the nurse champion and placed in her private 
office for my review. A vaccination data report was printed from the EMR using the 
check boxes for HPV. The nurse champion collected and stored all deidentified data 
regarding HPV vaccination rates and delivered those to me prior to and after the 
education in-service visit. The nurse champion directed me to the nurse commons on the 
day of the urgency statement delivery and in-service.  
Over the four-week period from the date of urgency poster delivery the total 
number of eligible visits and corresponding visits with checkboxes marked were included 
in the report. The nurse champion also reported that she informed providers how she 
would be tracking recommendation rates by using the meaningful use checkboxes in her 
report as part of this project. The vaccine champion noted that flu vaccine administration 
is up during winter months in the clinic and noted a significant increase in same day 
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referrals to the vaccine clinic within the first few days of the project during the post 
urgency in service period. The champion started tracking the available doses of the 
vaccines in order to prevent a limited supply or delay in administration. Adherence rates 
were added to the vaccination data report for my review. Although the adherence data 
was not tracked or included in the project outcome assessment as baseline data, the rates 
appeared to have meaningful significance showing that 60% (83/138 patients) of the 
patients receiving a recommendation for HPV did follow the recommendation given by 
their provider. Communities should be educated on cancer prevention as a priority with 
HPV vaccination. The healthcare provider should stay up to date on current trends and 
speak knowledgably on cancer prevention. No person should suffer the consequences of a 
preventable cancer or related treatment, including surgical complications, swallowing 
difficulty, depression, pain, infertility, or any of the countless other potential life 
changing effects from chemo and radiation therapies (Coley, Hoefer, & Rausch-Phung, 
2018). To significantly reduce infections and eliminate HPV-related cancers providers 
worldwide must remain advocates for their vulnerable patient populations locally and 
globally through education, policy advocacy and by avoiding personal bias and barriers 
to recommendation (Sussman et al., 2015). Education frameworks can be used across 
disciplines to make the kind of positive and measurable impacts to prevent disease in 
nursing, medicine, social sciences, and beyond. Vast positive social changes can be made 
to promote health as it relates to sexually transmitted HPV and elimination of associated 
cervical and oral cancers locally and globally. HPV infection is pandemic, and the 
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intervention will have the potential to make positive impacts on our local, national and 
even global communities (Fedewa et al., 2018). 
DNP Leaders as Team Members 
As a DNP project leader, I was responsible for providing peer reviewed evidence-
based practice recommendations to the practice site, communicating effectively with the 
medical director and acting as a liaison between the vaccine champion and project 
outcomes. I delivered an urgency statement poster and in-service to the medical director 
directly on the state of HPV infection and results from the providers surveys and 
vaccination data reports were de identified and discussed with the medical director. I 
transferred all data from vaccination reports into the Excel spreadsheet and shredded all 
project documents myself. Communication with the medical director and vaccine nurse 
was imperative throughout the project and was deemed effective by staying on the 
projected timeline for project. Outcomes from the project will be shared with the medical 
director by providing a copy of the final DNP project paper to the director once the paper 
meets committee final approval. Legislative Support is imperative for the advancement of 
policies brought forward by advanced practitioners (IOM, 2010). Using the lens of the 
McMaster Health Forum or EVIPNet framework the policy does show evidence of being 
informed and considers the main opposition stakeholders and supporters as well.  
Strengths and Limitations 
Although the clinic did not have a way of tracking vaccine recommendations 
through the walk-in clinic, I felt it was important to include all providers in the education 
framework within this project. All providers, even those working in the walk-in clinic, 
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occasionally rotated through the in-office clinic to see patients. Providers working in the 
walk-in clinic were included in the barrier assessment and were given the opportunity to 
review the urgency statement on HPV. The patients seen in the walk-in clinic were not 
included in the total recommendation assessment, but the provider would be prepared to 
educate and recommend the vaccine to their patients when they were being evaluated 
later in the in-office clinic. While the DNP project was able to demonstrate a quality 
improvement outcome for the clinic there were two major limitations in terms of access 
to the clinical site providers. First, limited numbers of providers were able to attend the 
in-service because the designed program was a one-day presentation and only the 
working provider group was able to hear the information on HPV urgency from me. The 
rest of the providers were relayed the information through the medical director upon their 
return to work. Initially, the project plan was to in service all providers on the HPV 
urgency statement through in-service. In service was limited to the provider group that 
was on staff the day of the scheduled in-service. The HPV urgency statement was 
delivered to the medical director and the in service was delivered to him directly. The full 
in-service was not presented to all the providers in the clinic. Because the pre assessment 
survey group and post assessment survey group were different groups of providers 
comparisons of barriers between groups could not be made. Regardless of these access 
barriers the medical director and the vaccine champion did relay all appropriate 
information to the staff and the HPV urgency poster was posted in the centralized area. A 
mixed methods study evaluated the 15-year trends of cervical and oropharyngeal cancer, 
finding that as a result of screening and vaccine the cervical cancers have declined, but 
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oropharyngeal cancers have continued to rise (Sussman et al., 2015). A clinician 
questionnaire was used to survey external factors and barriers that had potential influence 
on vaccination adherence. Sociocultural behaviors, media and policy were evaluated, and 
providers reported a variety of challenges to vaccination recommendation. It was found 
that only 9% of eligible adolescents received complete series to vaccination. 
Recommendations included a set of counseling strategies for overcoming identified 
barriers to vaccination recommendation. Researchers found that the results of this study 
were consistent with other recently published qualitative research studies (Sussman, et 
al., 2015). Clinicians who focused on cancer prevention rather than sexual activity 
counseling had a stronger adherence to vaccination (Sussman et al., 2015). The article 
supports the DNP project efforts to encourage provider recommendation by reporting the 
scientific state of urgency behind rising infection and related mortality. The medical 
director and the vaccine champion instructed the providers on appropriate documentation 
that was a perceived positive and independent result of the project. While documentation 
may be a large part in the overall increase in recommendation rates, it is believed to have 
improved the practice process on tracking education and likely will improve 
reimbursement from payers, however, the reimbursement improvements were not 
evaluated as part of the project.  
All data reports and surveys were collected and reviewed during the appropriate 
timeline. Overall the goal of increasing provider recommendation to HPV is 
demonstrable within this project, as 82 additional recommendations were charted during 
the post urgency four-week time period. Secondly, because visits on vaccination 
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recommendation were tracked only through the check box system, the clinic was also 
unable to track any separate visits that occurred as a result of a walk-in clinic or 
vaccination clinic visit. Our project only measured recommendation rates that occurred 
through a scheduled visit check box evaluation. Clinics with specialty providers have an 
inter collaborative approach and are increasingly likely to appoint vaccine champions, 
use standardized policies and schedule appropriate time to visits scheduled for 
vaccination (Lollier, et al., 2018). Evidence supports a systems-process-outcomes 
evaluation because HPV is not a reportable disease. The CDC has an approved self-
survey module for providers that has 5 questions on the epidemiology of HPV that will 
examine the providers’ knowledge base of HPV and vaccination data that follows the 
CDC recommendation (Vaccines CDC, 2019). While the eligible age for HPV vaccine is 
9-45 years, the CDC recommends that a two series vaccine be given at least 6 months 
apart to 11 and 12-year-old children. Data shows that two series vaccine protects best if 
received before age 15 or before sexual activity has started (CDC, 2019).  
A limitation to provider recommendation may have been that at baseline the 
providers were not told how information on how tracking documentation was relayed to 
the project leader. If the providers were recommending HPV vaccine before the project, 
but were not documenting through the checkbox system, the poor tracking could have 
been an explanation for why the rates of recommendation were reported to be so low 
(3%). The American Cancer Society addresses the problem of poor provider vaccination 
rates/recommendations by working as a direct partner in health initiatives and program 
development in collaboration with CDC. A new set of initiatives have been created and 
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approved with new goals for vaccination of HPV focusing on reaching 80% adherence by 
2026 (Fedewa et al., 2018). The HPM considers how behavioral factors within the 
provider population affects whether the provider makes the recommendation to vaccinate. 
Providers may have their own personal beliefs or opinions that present as barriers to 
recommendation for HPV vaccine. Pender’s HPM applies theory to address the 
disparities in health between males and females in receiving HPV vaccination. 
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Section 5: Dissemination Plan 
Introduction 
The multispecialty clinic has demonstrated the importance of the assessment of 
barriers toward vaccination using the Social Cognitive Theory and Pender’s HPM to 
measure how education influences provider rates of recommendation to create change in 
the outpatient setting. Measurably higher rates of HPV vaccine recommendation occurred 
in educational frameworks. Clarifying the audiences and venues that would be 
appropriate for dissemination the QI project enables me to make impacts to the broader 
nursing profession and healthcare’s social platform in our community. In Section 5, I will 
discuss how the DNP project will define how I may translate the QI findings into 
meaningful application into clinical sites and within the nursing profession. The QI 
outcomes proved to have public health implications toward prevention of disease and 
associated cancer. The focus for forward movement in change will be in policy advocacy 
and creation of legislation around vaccination and provider documentation platforms. 
Institution Plan 
The final DNP project results were shared with the medical director overseeing 
the project. All documents, surveys, and deidentified worksheets were reviewed by the 
director before the findings were summarized. Specifically, I reviewed the figures that I 
created for the Findings and Implications section of the project showing how the 
vaccination recommendations increased after education. The figures created to explain 
provider barriers were also reviewed with the director. Our meeting was a brief one-on-
one interaction, and the figures aided me in delivering a timely and poignant review of 
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the outcomes of the study. I provided the medical director with a copy of the figures to 
share with the clinical practice group. The key to ensuring the project results were 
representative of the evidence meant that I was able to translate the findings in a 
meaningful way. Stakeholders and end users within any health care practice area must 
demonstrate the ability to recognize practice problems and translate evidence into 
solutions (Leung, Trevana, & Waters, 2014).  
Nursing Profession Dissemination 
The ANA 2014 described how advanced nursing leaders are especially equipped 
to translate research into clinical practice by using patient centric advocacy, education 
and leadership to improve healthcare delivery to patients and communities. I have used 
the DNP essentials to explicitly gain liaisons in healthcare to bridge the gaps in 
knowledge and policy toward improved patient care outcomes. My DNP project mentor 
and I have used the research to show the need for change in vaccination efforts and 
recommendation in providers within our community. The focus on HPV vaccination has 
turned from prevention of an STD to a cancer prevention modality. Although advanced 
practice nurses understand the ongoing barriers that exist in our state and our nation, we 
also are increasingly equipped with ways to overcome these barriers. The nursing 
profession stands as the base I may rely on to have my voice heard in a post empirical 
viewpoint. Placing nursing professionals at the forefront of education makes them a 
crucial part of the Workforce Development team to help address disparities in cancer 
related HPV prevention strategies (Senkomago et al., 2017). Senkomago et al. (2017) 
described how despite rural and low-income countries having lack of access barriers, the 
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Global Initiative for Cancer Registry Development has a goal to reach 150 countries 
participating in advocacy and collaboration networks. HPV has been identified as the 
cause for nearly all cervical cancers, some of the vaginal cancers and most oropharyngeal 
cancers around the world (Senkomago et al., 2017). As HPV infection and related cancers 
are continuing to climb, global initiatives for surveillance and vaccination are becoming a 
priority (Senkomago et al., 2017).  
Analysis of Self 
Practitioner 
Using program evaluations sets the framework for the DNP who are positioned to 
move change forward, create buy in, and implement leadership by calling on assimilated 
program design and programs to bridge gaps in systems and demonstrate the need for 
change (Pritham, 2016). An example of a QI program design is knowing how to develop 
validated or standardized tools and incorporate those into practice settings. The CE 
module from the CDC tool has been validated in the literature and now is translated to 
use through the vaccination recommendation process and is considered a program design 
and evaluation. As a practitioner, I often used technology and HIT frameworks to 
document my care. Through the DNP project, I have come to understand how HIT 
develops standards to track and evaluate both disease specific data and tracks provider 
treatments and standard of care delivery. If the urgency statement on HPV is validated 
into an electronic platform, the data can be tracked from provider to provider and the 
system could even drive outcome measures to patient knowledge setting the bar for the 
level of understanding required before undergoing vaccination (Sherrod, & Goda, 2016). 
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There are cost-reduction implications to these systems that have yet to be evaluated as 
part of DNP project.  
Scholar  
As with the other quality improvement projects I have worked on throughout the 
practicum, using QI methodology proved to have positive effects on my ability to 
demonstrate leadership and create change. I have always valued the transformational 
leadership skills that come from being able to show how research and validated tools may 
be implemented into practice. For the practicum this term, the leadership strategy behind 
research translation and collaboration reached new application. The research that I did on 
HPV vaccination strategies was shared with my mentor. Dr Carlson is a speaker for the 
Head and Neck Maxillofacial Department and was a guest speaker for the Big 4 Cancer 
Conference held in the region where he delivered a speech on HPV-related cancers and 
cited my research to deliver up-to-date status on the infection and prevention strategies. I 
feel that I have been able to share my knowledge on research translation and effective 
collaborate in a multidisciplinary way throughout the DNP project. The DNP as a policy 
developer holds a key position as part of the healthcare team and should understand 
current policy and barriers to work on topics such as vaccination before moving forward 
to make a stance against or for a purposed change (IOM, 2010). Tenn. Code. Ann 68-10-
104 aims to give Tennessee adolescents care for STDs upon diagnosis but does not 
explicitly state vaccination as part of STD prevention or cancer prevention as an option to 
access (English, Bass, Boyle, & Eshragn, 2010). The Tennessee Attorney General has 
worked with Tennessee to define a “mature minor rule” for personal consent allowances. 
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The rule states that minors between the ages of 14-18 have a specific “capacity to 
consent” for treatments centered around contraception, prenatal care, STD treatment and 
screening, and drug and alcohol addiction (English et al., 2010). As a DNP student 
scholar, I have come to understand how transformational leadership may aid in the 
translation of EBP to clinical practice. Guidelines of transformational leadership suggest 
that new practice standards should include development of a team developed vision 
statement for clinical practices. The use of a vision statement in PICO format supported 
engaging nonbiased care and provided leaders a framework to deliver the essential 
characteristics of education and recommendation toward vaccination. Applying empathy 
towards healthcare workers translated into inspiring quality care delivery to patients 
(Abdullah et al., 2014).  
Project Manager 
The Future of Nursing Report from the IOM aims to provide support for ongoing 
education and quality improvement projects that can measure positive patient outcomes 
(IOM, 2010). In the DNP project, I believe managing the project on HPV vaccination 
recommendation helped the project site toward application and evaluation of their 
personal delivery style of HPV vaccination information and helped them adjust to gaps in 
knowledge of personal bias. The pre- and post-education survey tool was a 
nonthreatening way to measure barriers to vaccine recommendation without penalty. In 
today’s healthcare model of declining reimbursement identifying strategies to improve 
delivery is an important support needed for providers. The multidisciplinary efforts in the 
primary provider HPV vaccination recommendation project were helpful to me as a DNP 
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student. My leadership style allowed for increased collaboration efforts to be 
implemented and helped the attending doctor see how the utilization of a team in teaching 
was better than a single NP project initiative. The additional support of the team members 
was vital to the success of the project. The clinic does not use an electronic tracking 
system in all ancillary clinics, which is a major limitation to measuring outcomes and 
demonstrating tool effectiveness to stakeholders for ongoing projects. Whereas if the 
EHR was implemented in all branches of the clinic and not solely the routine office visits, 
the information and effects on outcomes would be more easily shown.  
Challenges and Insights 
Project barriers of lack of knowledge and time were the main provider focused 
barriers to implementation of the project. However, providers support the idea of 
transcending self-awareness and team approach that is required for change (Leonard-
McRae, 2017). The EBM used current knowledge, skill level, and attitude assessment 
through psychological questionnaires to develop the need for common barriers to 
recommendation to HPV vaccine in practice. By using the HPM Model, 
Transformational Leadership and EBM the practice can continue patient improvement 
outcome measures, apply knowledge translation by developing a common vision 
statement and recommendation and reduce variation in care delivered creating strong 
interpersonal relationships and positive workplace culture (Leung et al., 2014). In quality 
improvement change projects, success or failure comes from internal factors that include 
the project leader’s ability to demonstrate urgent vision, engage other leaders, gain 
resources toward change and demonstrate measurable outcomes (Solberg, 2007). Solberg 
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2007 explains how transformational program design is crucial to the success of patient 
centric change. For pedagogical intervention in the population of multispecialty providers 
to show a way to measure improvement in outcomes and is geared toward engaging 
systems, employee and patients alike toward change. QI projects, when done effectively, 
increase levels of knowledge in the patient. The strategies toward inter professional 
collaboration were strongly implemented with stakeholders on this project including IRB, 
clinical providers, medical director MD, the vaccine champion nurse and APN and 
patient revealing potential benefit for ongoing research (Braithwaite et al., 2013) 
Patient centered care integration relates to programs that increase efficiency and 
quality (Garcia, et al.2019). DNP professionals measure, document and evaluate the 
effectiveness of recommendation, therefore, effectively follow a quality improvement 
methodology. There are no directly visible barriers within the context of the project site 
as all stakeholders demonstrated acceptance for the project and assessment process. 
Funding around movement to EHR checkbox systems was not discussed in ongoing 
change projects. The project facility has adopted an EHR to comply with CMS 
meaningful use guidelines, therefore, any additional electronic support would be easily 
incorporated into the existing system despite some additional costs. 
Summary 
It was the aim and purpose of the DNP project to use an educational framework to 
assess a QI outcome toward provider recommendation rates toward HPV vaccination. 
The project did reveal a QI outcome in the multispecialty clinic site revealing compelling 
data that links higher rates of recommendation toward vaccination in provider groups that 
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receive a framework in which to become educated about HPV vaccination. The urgency 
statement developed for the project provides support from resources validated by the CE 
module from the CDC and ACS initiatives. The Healthy People Goals of 2026 serve as a 
reminder for clinicians in multispecialty clinics to refer to in efforts toward vaccination 
recommendation that encourages all adolescents receiving vaccination before their 13th 
birthday (Fedewa et al., 2018). The urgency statement created for this project 
incorporates all current state of science on HPV vaccination as a primary cancer 
prevention strategy. As HPV-related cancer incidence continues to climb and 
transmission of disease has reached 45% of the adult population in the US, the urgency of 
HPV vaccination is requiring translation to practice strategies like those suggested in the 
HPM pedagogy applied for our project (Senkomago et al., 2017). It has been projected 
that nearly all sexually active adults will have been exposed to HPV in their lifetime and 
now is the time for prevention through vaccination to become a national standard to care 
here in the United States and abroad. There is a direct and measurable link between 
recommendation for HPV vaccination and adherence to the vaccine (Niccolai et al., 
2018). If vaccination adherence reaches the 80% rate it is predicted that essentially all 
HPV infections will be eradicated, and HPV associated cancers will be reduced to less 
than 20% globally (Niccolai et al., 2018). Social change through quality improvement 
can be directly measured in the case of HPV vaccination recommendation.    
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Appendix A: WD4019: You Are the Key to HPV Cancer Prevention-2018 
 
1. The perceived and real concerns of parents influence how clinicians recommend the HPV 
vaccine toward 
A. HPV, Tdap, meningitis 
B. Hep B, Tdap, meningitis 
C. HPV, Hep B, Tdap 
D. Other adolescent vaccines, pertussis, Hepatitis, HPV 
2. Some parents may still be interested in vaccinating yet still have questions. Ask parents about 
their main concerns and use the You Call the Shots self-study modules offering responses  
A. Parental attitudes “We’ll give the shots at the end of the visit. Do you have any 
questions for me?’ 
B. Low perceived benefits “We can help prevent infection types of HPV that can cause 
cancers by starting the vaccine series today” 
C. Social Influences “HPV vaccination is important because it prevents cancer” & 
“HPV vaccine does not make your kids more likely to engage in sexual activity” 
D. Concern for adverse reactions with vaccinations “I have researched the HPV vaccine 
including safety. Can I share with you what I’ve learned?” 
E. Irregular preventative care “When you check out please make an appointment for 6 
months from now.” 
3. HPV has been linked to cervical cancer in women and oropharyngeal cancer in women and 
men, in evaluating trends from the years between 2014-2019 
A. Cervical Cancer is continuing to rise, While Oropharyngeal has decreased 
B. Cervical and oropharyngeal cancers continue to rise 
C. Cervical cancers have decreased while oropharyngeal cancers continue to rise 
D. Both cervical and oropharyngeal cancers are now on the decline 
4. There are concerns about safety related to vaccination. The CDC is supported by: 
A. Reactions may include ever, headaches and injection site redness and pain  
B. HPV vaccines are safe 
C. Brief fainting spells (syncope) can occur after any injection including HPV 
D. Patients should be sitting (or lying) during the injection and remain that way for 15 
minutes 
5. Explain the recommendations for HPV vaccine to adolescents and their parents by: 
A. Boys and girls aged 9-14 should receive HPV vaccine (series of 2) or if 15 or older 
(series of 3) to prevent cancer regardless of sexual activity status. 
B. Boys and girls should receive the vaccine before their 13th birthday 
C. The HPV vaccine (series of 2) should be given to all eligible adolescents age 11-12 
years old, with the second dose given 6-12 months from the first 
D. Boys and girls can start the vaccine at age 9 
 
www.cdc.gov/vaccines/ed/hpv/you-are-key-2018.html  
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without 
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Research on 
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research 
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access of 
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Sussman, A., 
Helitzer, D.,  
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Solares, A.,} 
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& Getrich, C. 
(2015) 
 
Behavioral  
Model 
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Vaccination 
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not being 
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strong 
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with clinicians 
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health 
delivery 
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not 
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Interventions 
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communicati
on and 
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priority to 
improving 
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and 
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other venues 
outside of 
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community 
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Appendix C: HPV Urgency Statement for Multispecialty Providers 
1. Appreciate the significance of meeting the CDC’s HPV vaccination 
recommendation rate of 80%. Human Papillomavirus (HPV) is the most common sexually 
transmitted disease in the United States in 2018 (Van Dyne et al., 2018). The Centers for Disease 
Control and Prevention (CDC) established the Healthy People 2020 initiative for HPV vaccination 
uptake of 80% in effort to effectively eliminate the HPV associated cancers. Both men and women are 
being diagnosed with HPV related cancers despite health care initiatives and provider awareness 
campaigns. With 14 million new cases per year in the United States alone, the American Cancer 
Society has made new a new goal for the year 2026 that would support that 80% of pre-teens 11-12 
years old will receive the vaccine before their 13th birthday (Fedewa et al., 2018). 
2. Acknowledge the importance of your recommendation and considered bundling 
your recommendation with the other age-related school entry vaccines. The tdap, 
meningitis, and flu vaccines all have adherence rates greater than 80% The World Health Organization 
(WHO) data demonstrates that despite vaccination efforts and screening these numbers are now 
globally reaching 570,000 HPV related cancers in women and 60,000 cancers in men per year (St. 
Laurent, Luckett, & Feldman, 2018). If vaccination rates reach the 80% goal, vaccine models suggest 
that the HPV infection would be completely eradicated, and cancer deaths could be reduced to 20% 
globally (Brisson et al., 2016). 
3. Motivate your team and include parents on the discussion around HPV 
vaccination as it relates to HPV related cancers. HPV has been identified as the cause for 
nearly all cervical cancers, some of the vaginal cancers and most oropharyngeal cancers around the 
world (Senkomago et al., 2017). As HPV infection and related cancers are continuing to climb, global 
initiatives for surveillance and vaccination are becoming a priority (Senkomago et al., 2017). 
Clinicians using a thematic approach to evaluate the social impacts and barriers to HPV vaccination 
recommendation find that a strong recommendation from a provider is highly motivating for the parent 
and patient in terms of vaccination adherence (Niccolai, North, Footman, & Hausen, 2018). When 
addressing anti vax concerns and issues about side effects try stating “I have researched the HPV 
vaccine including safety. Can I share with you what I’ve learned?”  
4. Know your rates of recommendation and refusal so you may help develop 
solutions to barriers. Locally the public commissioner of health and the CDC have reported that 
while nationally HPV vaccination rates among eligible adolescent patients are recorded at 40%, our 
state records an even lower uptake of vaccination of 30% (HPV Vaccines, 2018). The problem of HPV 
infection is reaching 45% of the US population and is anticipated to grow if states do not react to find 
vaccination compliance strategies (HPV Vaccines, 2018). The Mid-Atlantic region falls along a 
religious beltway in the United States that sets precedent for religious beliefs to impact vaccination 
adherence. The religiously exempt students make up the largest group of unvaccinated kids in the 
county with just under 2% claiming this exemption (Capps, 2019). The County Health Department 
reports that there are higher numbers of parents reporting lack of access to care related to time and 
travel to care centers compared to anti vaccination philosophies (Capps, 2019 para. 7). The clinics 
approximate current recommendation rate is 3%. 
5. Understand how to overcome barriers to HPV vaccine. The federal initiative for public 
health on HPV vaccination is called the Hub and Spoke Initiative (American Academy of Pediatrics 
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[AAP], 2019). In a collaboration with the CDC and the AAP the Community Guide and the Hub and 
Spoke Initiative were formed. The priority of the Hub and Spoke Initiative is to focus on creating peer 
guided accountability on strong provider recommendations for vaccination against HPV (AAP, 2019). 
The cultural, ethical, and legal obligations to promote wellness through vaccination becomes 
imperative in the framework of preventing the spread of HPV infection, because infections are directly 
related to higher risk for cancer (AAP, 2019). With any illness that is spread due to sexual 
transmission a stigma and fear may present, not just in the parental community, but the provider one as 
well (Fedewa et al., 2018). The National Committee of Immunization and Research (NCIR) and the 
Advisory Committee on Immunization Practices (ACIP) have defined evidenced based guidelines for 
HPV vaccination that the CDC used to create the module (Health and Human Services, 2019). The 
CDC has a wide scope initiative for HPV vaccination and program that includes references and tools 
for clinicians contained in the HPV Toolkit and has an assigned approved Office of Management and 
Budget (OMB) # 0990-0379 (Health and Human Services, 2019). The tool includes five major item 
sections of content that measures learning objectives in the areas of HPV vaccine as cancer prevention, 
indications for the vaccines in boys and girls, components of vaccine recommendations, relevant and 
compelling information on the vaccine for parents, and disease prevention risks and strategies (Health 
and Human Services, 2019). In efforts to identify the barriers to meeting vaccination rates community 
leaders around the world have made poor HPV vaccination rates a global pandemic priority (Fedewa et 
al., 2018). Cervical cancer has trended downward in the last fifteen years, but cervical and oral cancer 
diagnoses continue to reach numbers larger than 500,000 per year (Senkomago et al., 2017). There is 
significance in HPV vaccination as a public health problem because after more than a decade of HPV 
vaccination awareness, providers are still coming up short with recommendations to vaccinate 
(Niccolai, et al., 2018). Recommendations to vaccinate have been identified as the most significant 
predictor of vaccination adherence among the pre-teen population (Niccolai, et al., 2018). 
 
 
 
*This statement was developed using resources from the CDC HPV Toolkit, CE 
Module: WD4019: You Are The Key To HPV Cancer Prevention 2019, Health and 
Human Services Public Access Article (Holman et al., 2015) and the DNP Project 
Literature Review titled “Primary Provider Education Increasing Knowledge and 
Recommendation for Human Papillomavirus Vaccination “and the American 
Academy of Pediatrics 2019. 
